Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology 
|9-4-1-1|1|100|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-2|1|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-3|1|346|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-4|1|374|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-5|1|403|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-6|1|415|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-7|1|435|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-8|1|439|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-9|1|445|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-10|1|452|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-11|1|458|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-12|1|478|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-13|1|482|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-14|1|489|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-15|1|496|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-16|1|497|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-17|1|507|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-18|1|514|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-19|1|520|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-20|1|520|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-21|1|523|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-22|1|524|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-23|1|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-24|1|536|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-25|1|540|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-26|1|546|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-27|1|558|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-28|1|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-29|1|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-30|1|592|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-31|1|593|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-32|1|593|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-33|1|595|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-34|1|605|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-35|1|606|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-36|1|619|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-37|1|623|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-38|1|624|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-39|1|631|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-40|1|635|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-41|1|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-42|1|638|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-43|1|639|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-44|1|646|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-45|1|647|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-46|1|649|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-47|1|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-48|1|654|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-49|1|664|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-50|1|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-51|1|679|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-52|1|685|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-53|1|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-54|1|689|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-55|1|698|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-56|1|700|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-57|1|703|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-58|1|704|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-59|1|709|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-60|1|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-61|1|721|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-62|1|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-63|1|724|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-64|1|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-65|1|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-66|1|742|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-67|1|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-68|1|745|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-69|1|748|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-70|1|752|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-71|1|753|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-72|1|755|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-73|1|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-74|1|764|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-75|1|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-76|1|782|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-77|1|790|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-78|1|801|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-79|1|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-80|1|813|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-81|1|819|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-82|1|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-83|1|820|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-84|1|826|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-85|1|830|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-86|1|833|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-87|1|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-88|1|847|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-89|1|847|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-90|1|848|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-91|1|849|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-92|1|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-93|1|852|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-94|1|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-95|1|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-96|1|862|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-97|1|864|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-98|1|868|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-99|1|872|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-100|1|874|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-101|1|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-102|1|879|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-103|1|880|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-104|1|882|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-105|1|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-106|1|882|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-107|1|883|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-108|1|883|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-109|1|887|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-110|1|889|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-111|1|890|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-112|1|894|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-113|1|895|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-114|1|901|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-115|1|905|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-116|1|909|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-117|1|917|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-118|1|923|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-119|1|923|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-120|1|927|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-121|1|927|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-122|1|928|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-123|1|929|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-124|1|929|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-125|1|930|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-126|1|941|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-127|1|947|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-128|1|949|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-129|1|952|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-130|1|964|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-131|1|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-132|1|975|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-133|1|979|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-134|1|979|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-135|1|986|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-136|1|993|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-137|1|1000|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-138|1|1009|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-139|1|1012|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-140|1|1026|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-141|1|1028|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-142|1|1036|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-143|1|1049|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-144|1|1055|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-145|1|1056|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-146|1|1059|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-147|1|1062|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-148|1|1064|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-149|1|1084|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-150|1|1109|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-151|1|1112|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-152|1|1136|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-153|1|1142|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-154|1|1145|Other deterministic changes|Lower respiratory system|n/a|
9-4-1|XB-Gy 0,n/a|1| 84|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|155 (155 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-1-155|1|1199|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-1|2|61|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-2|2|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-3|2|266|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-4|2|274|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-5|2|414|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-6|2|452|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-7|2|452|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-8|2|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-9|2|482|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-10|2|493|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-11|2|504|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-12|2|515|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-13|2|520|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-14|2|520|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-15|2|521|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-16|2|523|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-17|2|526|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-18|2|529|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-19|2|530|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-20|2|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-21|2|535|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-22|2|537|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-23|2|543|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-24|2|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-25|2|554|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-26|2|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-27|2|567|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-28|2|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-29|2|595|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-30|2|596|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-31|2|609|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-32|2|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-33|2|618|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-34|2|630|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-35|2|635|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-36|2|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-37|2|651|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-38|2|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-39|2|671|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-40|2|674|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-41|2|683|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-42|2|685|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-43|2|686|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-44|2|691|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-45|2|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-46|2|702|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-47|2|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-48|2|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-49|2|711|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-50|2|714|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-51|2|715|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-52|2|718|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-53|2|727|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-54|2|727|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-55|2|728|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-56|2|743|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-57|2|747|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-58|2|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-59|2|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-60|2|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-61|2|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-62|2|749|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-63|2|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-64|2|752|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-65|2|753|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-66|2|757|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-67|2|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-68|2|759|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-69|2|759|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-70|2|761|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-71|2|764|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-72|2|765|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-73|2|765|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-74|2|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-75|2|776|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-76|2|784|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-77|2|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-78|2|796|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-79|2|798|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-80|2|800|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-81|2|804|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-82|2|804|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-83|2|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-84|2|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-85|2|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-86|2|817|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-87|2|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-88|2|820|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-89|2|824|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-90|2|833|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-91|2|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-92|2|838|Other deterministic changes|Whole body|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-93|2|841|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-94|2|841|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-95|2|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-96|2|847|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-97|2|850|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-98|2|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-99|2|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-100|2|862|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-101|2|863|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-102|2|868|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-103|2|868|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-104|2|871|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-105|2|874|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-106|2|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-107|2|877|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-108|2|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-109|2|890|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-110|2|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-111|2|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-112|2|893|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-113|2|896|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-114|2|897|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-115|2|898|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-116|2|904|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-117|2|907|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-118|2|908|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-119|2|909|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-120|2|913|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-121|2|914|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-122|2|914|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-123|2|915|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-124|2|919|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-125|2|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-126|2|921|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-127|2|923|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-128|2|926|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-129|2|926|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-130|2|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-131|2|930|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-132|2|932|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-133|2|933|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-134|2|944|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-135|2|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-136|2|957|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-137|2|962|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-138|2|985|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-139|2|989|Other deterministic changes|Lower respiratory system|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-140|2|994|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-141|2|1008|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-142|2|1008|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-143|2|1027|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-2|XB-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|144 (144 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-2-144|2|1029|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-1|3|109|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-2|3|116|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-3|3|160|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-4|3|186|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-5|3|252|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-6|3|262|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-7|3|282|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-8|3|296|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-9|3|309|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-10|3|355|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-11|3|360|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-12|3|404|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-13|3|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-14|3|438|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-15|3|458|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-16|3|461|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-17|3|465|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-18|3|467|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-19|3|468|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-20|3|471|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-21|3|476|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-22|3|481|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-23|3|485|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-24|3|489|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-25|3|490|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-26|3|494|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-27|3|495|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-28|3|498|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-29|3|506|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-30|3|506|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-31|3|512|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-32|3|517|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-33|3|517|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-34|3|518|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-35|3|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-36|3|525|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-37|3|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-38|3|535|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-39|3|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-40|3|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-41|3|544|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-42|3|545|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-43|3|548|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-44|3|555|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-45|3|564|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-46|3|576|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-47|3|589|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-48|3|598|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-49|3|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-50|3|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-51|3|616|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-52|3|618|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-53|3|625|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-54|3|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-55|3|636|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-56|3|656|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-57|3|662|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-58|3|669|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-59|3|675|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-60|3|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-61|3|676|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-62|3|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-63|3|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-64|3|699|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-65|3|700|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-66|3|701|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-67|3|704|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-68|3|706|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-69|3|707|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-70|3|710|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-71|3|711|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-72|3|712|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-73|3|725|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-74|3|729|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-75|3|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-76|3|741|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-77|3|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-78|3|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-79|3|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-80|3|759|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-81|3|762|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-82|3|768|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-83|3|770|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-84|3|774|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-85|3|775|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-86|3|775|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-87|3|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-88|3|779|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-89|3|780|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-90|3|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-91|3|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-92|3|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-93|3|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-94|3|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-95|3|793|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-96|3|794|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-97|3|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-98|3|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-99|3|811|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-100|3|813|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-101|3|817|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-102|3|817|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-103|3|824|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-104|3|829|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-105|3|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-106|3|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-107|3|843|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-108|3|843|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-109|3|854|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-110|3|866|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-111|3|867|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-112|3|867|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-113|3|869|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-114|3|874|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-115|3|874|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-116|3|875|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-117|3|876|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-118|3|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-119|3|879|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-120|3|885|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-121|3|885|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-122|3|888|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-123|3|896|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-124|3|897|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-125|3|897|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-126|3|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-127|3|900|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-128|3|900|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-129|3|905|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-130|3|912|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-131|3|926|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-132|3|935|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-133|3|938|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-134|3|938|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-135|3|959|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-136|3|965|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-137|3|970|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-138|3|993|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-139|3|993|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-140|3|997|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-141|3|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-142|3|1027|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-143|3|1030|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-144|3|1031|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-145|3|1042|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-146|3|1047|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-147|3|1051|Other deterministic changes|Lower respiratory system|n/a|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-148|3|1052|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-3|XB-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|149 (149 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-3-149|3|1056|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-1|4|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-2|4|211|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-3|4|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-4|4|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-5|4|266|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-6|4|267|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-7|4|293|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-8|4|301|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-9|4|317|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-10|4|324|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-11|4|326|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-12|4|332|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-13|4|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-14|4|337|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-15|4|341|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-16|4|341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-17|4|343|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-18|4|344|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-19|4|351|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-20|4|363|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-21|4|375|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-22|4|382|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-23|4|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-24|4|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-25|4|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-26|4|417|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-27|4|424|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-28|4|425|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-29|4|445|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-30|4|447|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-31|4|463|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-32|4|473|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-33|4|478|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-34|4|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-35|4|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-36|4|492|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-37|4|494|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-38|4|501|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-39|4|514|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-40|4|516|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-41|4|518|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-42|4|530|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-43|4|543|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-44|4|548|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-45|4|552|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-46|4|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-47|4|557|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-48|4|557|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-49|4|566|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-50|4|567|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-51|4|597|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-52|4|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-53|4|615|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-54|4|617|Other deterministic changes|Whole body|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-55|4|618|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-56|4|618|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-57|4|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-58|4|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-59|4|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-60|4|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-61|4|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-62|4|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-63|4|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-64|4|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-65|4|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-66|4|695|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-67|4|708|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-68|4|711|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-69|4|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-70|4|716|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-71|4|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-72|4|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-73|4|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-74|4|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-75|4|729|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-76|4|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-77|4|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-78|4|732|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-79|4|744|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-80|4|748|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-81|4|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-82|4|750|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-83|4|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-84|4|760|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-85|4|770|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-86|4|772|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-87|4|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-88|4|781|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-89|4|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-90|4|788|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-91|4|789|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-92|4|793|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-93|4|794|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-94|4|798|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-95|4|805|Other deterministic changes|Whole body|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-96|4|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-97|4|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-98|4|823|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-99|4|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-100|4|846|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-101|4|852|Other deterministic changes|Lower respiratory system|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-102|4|868|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-103|4|905|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-104|4|909|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-105|4|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-106|4|962|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-4|XB-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|107 (107 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-4-107|4|971|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-1|5|61|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-2|5|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-3|5|98|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-4|5|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-5|5|196|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-6|5|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-7|5|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-8|5|221|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-9|5|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-10|5|224|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-11|5|234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-12|5|245|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-13|5|252|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-14|5|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-15|5|259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-16|5|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-17|5|313|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-18|5|314|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-19|5|328|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-20|5|343|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-21|5|352|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-22|5|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-23|5|366|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-24|5|370|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-25|5|372|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-26|5|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-27|5|416|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-28|5|422|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-29|5|434|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-30|5|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-31|5|455|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-32|5|475|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-33|5|480|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-34|5|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-35|5|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-36|5|486|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-37|5|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-38|5|518|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-39|5|522|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-40|5|539|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-41|5|568|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-42|5|587|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-43|5|588|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-44|5|589|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-45|5|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-46|5|600|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-47|5|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-48|5|603|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-49|5|608|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-50|5|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-51|5|628|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-52|5|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-53|5|638|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-54|5|651|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-55|5|666|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-56|5|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-57|5|700|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-58|5|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-59|5|712|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-60|5|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-61|5|743|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-62|5|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-63|5|756|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-64|5|777|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-65|5|782|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-66|5|789|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-67|5|824|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-68|5|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-69|5|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-70|5|861|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-71|5|864|Other deterministic changes|Lower respiratory system|n/a|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-72|5|873|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-73|5|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-74|5|892|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-75|5|897|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-5|XB-Gy 5,n/a|1| 84|X-rays whole body|500|roentgens|External exposure| whole body single|76 (76 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-5-76|5|925|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-1|6|70|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-2|6|95|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-3|6|100|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-4|6|147|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-5|6|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-6|6|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-7|6|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-8|6|160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-9|6|166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-10|6|169|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-11|6|174|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-12|6|175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-13|6|177|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-14|6|180|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-15|6|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-16|6|194|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-17|6|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-18|6|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-19|6|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-20|6|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-21|6|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-22|6|213|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-23|6|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-24|6|224|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-25|6|230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-26|6|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-27|6|242|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-28|6|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-29|6|246|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-30|6|249|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-31|6|251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-32|6|255|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-33|6|257|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-34|6|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-35|6|258|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-36|6|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-37|6|266|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-38|6|276|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-39|6|279|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-40|6|280|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-41|6|283|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-42|6|285|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-43|6|285|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-44|6|286|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-45|6|286|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-46|6|288|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-47|6|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-48|6|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-49|6|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-50|6|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-51|6|298|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-52|6|302|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-53|6|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-54|6|314|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-55|6|317|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-56|6|318|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-57|6|318|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-58|6|325|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-59|6|327|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-60|6|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-61|6|329|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-62|6|329|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-63|6|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-64|6|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-65|6|336|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-66|6|342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-67|6|344|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-68|6|345|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-69|6|347|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-70|6|352|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-71|6|356|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-72|6|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-73|6|357|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-74|6|358|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-75|6|359|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-76|6|362|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-77|6|371|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-78|6|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-79|6|372|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-80|6|377|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-81|6|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-82|6|379|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-83|6|385|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-84|6|402|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-85|6|404|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-86|6|404|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-87|6|405|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-88|6|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-89|6|413|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-90|6|414|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-91|6|417|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-92|6|418|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-93|6|420|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-94|6|425|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-95|6|427|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-96|6|427|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-97|6|428|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-98|6|435|Other deterministic changes|Whole body|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-99|6|453|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-100|6|465|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-101|6|469|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-102|6|470|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-103|6|478|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-104|6|480|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-105|6|480|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-106|6|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-107|6|482|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-108|6|484|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-109|6|491|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-110|6|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-111|6|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-112|6|510|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-113|6|518|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-114|6|519|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-115|6|531|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-116|6|534|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-117|6|544|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-118|6|549|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-119|6|554|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-120|6|558|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-121|6|559|Other deterministic changes|Whole body|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-122|6|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-123|6|559|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-124|6|563|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-125|6|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-126|6|568|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-127|6|571|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-128|6|575|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-129|6|575|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-130|6|577|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-131|6|578|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-132|6|582|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-133|6|584|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-134|6|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-135|6|587|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-136|6|590|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-137|6|591|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-138|6|593|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-139|6|593|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-140|6|594|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-141|6|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-142|6|604|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-143|6|609|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-144|6|610|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-145|6|616|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-146|6|621|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-147|6|623|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-148|6|624|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-149|6|625|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-150|6|625|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-151|6|625|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-152|6|630|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-153|6|630|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-154|6|631|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-155|6|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-156|6|641|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-157|6|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-158|6|649|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-159|6|649|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-160|6|650|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-161|6|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-162|6|661|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-163|6|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-164|6|664|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-165|6|670|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-166|6|671|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-167|6|673|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-168|6|674|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-169|6|677|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-170|6|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-171|6|680|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-172|6|691|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-173|6|701|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-174|6|716|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-175|6|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-176|6|717|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-177|6|722|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-178|6|724|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-179|6|726|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-180|6|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-181|6|737|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-182|6|743|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-183|6|758|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-184|6|762|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-185|6|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-186|6|770|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-187|6|775|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-188|6|778|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-189|6|780|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-190|6|785|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-191|6|797|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-192|6|807|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-193|6|810|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-194|6|811|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-195|6|842|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-196|6|864|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-197|6|868|Other deterministic changes|Lower respiratory system|n/a|
9-4-6|XB-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|198 (198 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-6-198|6|927|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-1|7|136|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-2|7|176|Other deterministic changes|Whole body|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-3|7|177|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-4|7|180|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-5|7|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-6|7|197|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-7|7|202|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-8|7|226|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-9|7|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-10|7|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-11|7|232|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-12|7|239|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-13|7|258|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-14|7|268|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-15|7|284|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-16|7|288|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-17|7|292|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-18|7|298|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-19|7|312|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-20|7|315|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-21|7|329|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-22|7|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-23|7|333|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-24|7|338|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-25|7|340|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-26|7|347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-27|7|356|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-28|7|372|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-29|7|390|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-30|7|409|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-31|7|420|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-32|7|421|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-33|7|427|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-34|7|437|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-35|7|448|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-36|7|457|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-37|7|467|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-38|7|471|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-39|7|490|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-40|7|518|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-41|7|526|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-42|7|528|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-43|7|539|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-44|7|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-45|7|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-46|7|563|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-47|7|570|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-48|7|576|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-49|7|581|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-50|7|582|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-51|7|599|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-52|7|608|Other deterministic changes|Lower respiratory system|n/a|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-53|7|631|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-54|7|652|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-55|7|668|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-56|7|670|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-7|XB-Gy 7.5,n/a|1| 84|X-rays whole body|750|roentgens|External exposure| whole body single|57 (57 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-7-57|7|706|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-1|8|64|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-2|8|65|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-3|8|102|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-4|8|102|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-5|8|104|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-6|8|155|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-7|8|165|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-8|8|175|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-9|8|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-10|8|196|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-11|8|216|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-12|8|274|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-13|8|321|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-14|8|348|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-15|8|372|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-16|8|388|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-17|8|528|Other deterministic changes|Lower respiratory system|n/a|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-18|8|532|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-8|XB-Gy 9,n/a|1| 84|X-rays whole body|900|roentgens|External exposure| whole body single|19 (19 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-8-19|8|563|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-9|XBA-Gy 5,n/a|Sequence:1, Age:84,Type:X-rays whole body,Quantity:500,Unit:roentgens,Application:External exposure, Remarks:whole body single|160 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-9|XBA-Gy 5,n/a|Sequence:2, Age:84,Type:AET,Quantity:8,Unit:milligrams per animal,Application:Injection, intraperitoneal, Remarks:n/a|160 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-1|10|99|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-2|10|149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-3|10|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-4|10|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-5|10|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-6|10|234|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-7|10|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-8|10|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-9|10|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-10|10|250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-11|10|250|Other deterministic changes|Whole body|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-12|10|263|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-13|10|270|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-14|10|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-15|10|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-16|10|352|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-17|10|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-18|10|363|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-19|10|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-20|10|377|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-21|10|379|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-22|10|396|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-23|10|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-24|10|408|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-25|10|416|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-26|10|418|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-27|10|428|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-28|10|446|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-29|10|446|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-30|10|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-31|10|483|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-32|10|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-33|10|510|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-34|10|525|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-35|10|528|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-36|10|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-37|10|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-38|10|555|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-39|10|573|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-40|10|575|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-41|10|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-42|10|584|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-43|10|585|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-44|10|585|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-45|10|603|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-46|10|607|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-47|10|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-48|10|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-49|10|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-50|10|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-51|10|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-52|10|621|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-53|10|623|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-54|10|626|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-55|10|632|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-56|10|637|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-57|10|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-58|10|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-59|10|649|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-60|10|653|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-61|10|657|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-62|10|664|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-63|10|671|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-64|10|674|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-65|10|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-66|10|681|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-67|10|685|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-68|10|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-69|10|693|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-70|10|694|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-71|10|696|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-72|10|696|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-73|10|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-74|10|704|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-75|10|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-76|10|728|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-77|10|733|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-78|10|735|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-79|10|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-80|10|741|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-81|10|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-82|10|742|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-83|10|744|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-84|10|744|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-85|10|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-86|10|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-87|10|774|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-88|10|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-89|10|776|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-90|10|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-91|10|790|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-92|10|791|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-93|10|810|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-94|10|815|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-95|10|828|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-96|10|820|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-97|10|840|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-98|10|874|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-99|10|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-100|10|909|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-101|10|950|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-102|10|1055|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-1|10|99|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-2|10|149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-3|10|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-4|10|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-5|10|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-6|10|234|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-7|10|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-8|10|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-9|10|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-10|10|250|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-11|10|250|Other deterministic changes|Whole body|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-12|10|263|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-13|10|270|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-14|10|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-15|10|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-16|10|352|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-17|10|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-18|10|363|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-19|10|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-20|10|377|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-21|10|379|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-22|10|396|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-23|10|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-24|10|408|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-25|10|416|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-26|10|418|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-27|10|428|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-28|10|446|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-29|10|446|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-30|10|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-31|10|483|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-32|10|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-33|10|510|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-34|10|525|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-35|10|528|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-36|10|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-37|10|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-38|10|555|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-39|10|573|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-40|10|575|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-41|10|575|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-42|10|584|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-43|10|585|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-44|10|585|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-45|10|603|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-46|10|607|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-47|10|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-48|10|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-49|10|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-50|10|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-51|10|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-52|10|621|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-53|10|623|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-54|10|626|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-55|10|632|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-56|10|637|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-57|10|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-58|10|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-59|10|649|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-60|10|653|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-61|10|657|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-62|10|664|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-63|10|671|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-64|10|674|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-65|10|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-66|10|681|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-67|10|685|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-68|10|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-69|10|693|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-70|10|694|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-71|10|696|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-72|10|696|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-73|10|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-74|10|704|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-75|10|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-76|10|728|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-77|10|733|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-78|10|735|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-79|10|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-80|10|741|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-81|10|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-82|10|742|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-83|10|744|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-84|10|744|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-85|10|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-86|10|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-87|10|774|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-88|10|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-89|10|776|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-90|10|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-91|10|790|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-92|10|791|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-93|10|810|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-94|10|815|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-95|10|828|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-96|10|820|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-97|10|840|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-98|10|874|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-99|10|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-100|10|909|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-101|10|950|Other deterministic changes|Lower respiratory system|n/a|
9-4-10|XBA-Gy 6.5,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|102 (102 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-10-102|10|1055|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-1|11|67|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-2|11|80|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-3|11|89|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-4|11|92|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-5|11|129|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-6|11|140|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-7|11|146|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-8|11|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-9|11|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-10|11|166|Other deterministic changes|Whole body|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-11|11|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-12|11|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-13|11|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-14|11|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-15|11|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-16|11|198|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-17|11|200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-18|11|201|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-19|11|201|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-20|11|205|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-21|11|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-22|11|228|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-23|11|250|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-24|11|257|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-25|11|257|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-26|11|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-27|11|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-28|11|273|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-29|11|285|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-30|11|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-31|11|295|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-32|11|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-33|11|302|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-34|11|304|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-35|11|309|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-36|11|321|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-37|11|325|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-38|11|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-39|11|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-40|11|339|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-41|11|342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-42|11|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-43|11|362|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-44|11|363|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-45|11|370|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-46|11|391|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-47|11|395|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-48|11|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-49|11|406|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-50|11|449|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-51|11|460|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-52|11|469|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-53|11|476|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-54|11|478|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-55|11|495|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-56|11|499|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-57|11|501|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-58|11|515|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-59|11|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-60|11|530|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-61|11|533|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-62|11|541|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-63|11|553|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-64|11|559|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-65|11|571|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-66|11|588|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-67|11|611|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-68|11|621|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-69|11|633|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-70|11|636|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-71|11|638|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-72|11|652|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-73|11|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-74|11|656|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-75|11|664|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-76|11|736|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-77|11|772|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-1|11|67|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-2|11|80|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-3|11|89|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-4|11|92|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-5|11|129|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-6|11|140|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-7|11|146|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-8|11|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-9|11|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-10|11|166|Other deterministic changes|Whole body|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-11|11|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-12|11|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-13|11|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-14|11|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-15|11|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-16|11|198|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-17|11|200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-18|11|201|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-19|11|201|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-20|11|205|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-21|11|228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-22|11|228|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-23|11|250|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-24|11|257|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-25|11|257|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-26|11|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-27|11|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-28|11|273|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-29|11|285|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-30|11|393|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-31|11|295|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-32|11|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-33|11|302|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-34|11|304|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-35|11|309|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-36|11|321|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-37|11|325|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-38|11|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-39|11|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-40|11|339|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-41|11|342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-42|11|350|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-43|11|362|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-44|11|363|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-45|11|370|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-46|11|391|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-47|11|395|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-48|11|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-49|11|406|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-50|11|449|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-51|11|460|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-52|11|469|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-53|11|476|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-54|11|478|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-55|11|495|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-56|11|499|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-57|11|501|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-58|11|515|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-59|11|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-60|11|530|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-61|11|533|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-62|11|541|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-63|11|553|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-64|11|559|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-65|11|571|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-66|11|588|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-67|11|611|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-68|11|621|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-69|11|633|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-70|11|636|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-71|11|638|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-72|11|652|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-73|11|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-74|11|656|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-75|11|664|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-76|11|736|Other deterministic changes|Lower respiratory system|n/a|
9-4-11|XBA-Gy 10,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|77 (77 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-11-77|11|772|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-1|12|62|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-2|12|67|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-3|12|69|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-4|12|70|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-5|12|72|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-6|12|73|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-7|12|76|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-8|12|76|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-9|12|78|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-10|12|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-11|12|90|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-12|12|94|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-13|12|95|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-14|12|105|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-15|12|112|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-16|12|119|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-17|12|121|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-18|12|123|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-19|12|128|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-20|12|135|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-21|12|137|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-22|12|139|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-23|12|139|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-24|12|143|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-25|12|144|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-26|12|152|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-27|12|152|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-28|12|153|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-29|12|156|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-30|12|164|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-31|12|164|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-32|12|167|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-33|12|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-34|12|183|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-35|12|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-36|12|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-37|12|193|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-38|12|200|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-39|12|202|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-40|12|202|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-41|12|204|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-42|12|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-43|12|216|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-44|12|218|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-45|12|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-46|12|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-47|12|225|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-48|12|234|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-49|12|237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-50|12|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-51|12|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-52|12|243|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-53|12|243|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-54|12|245|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-55|12|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-56|12|248|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-57|12|294|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-58|12|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-59|12|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-60|12|298|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-61|12|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-62|12|307|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-63|12|317|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-64|12|343|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-65|12|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-66|12|352|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-67|12|353|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-68|12|355|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-69|12|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-70|12|378|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-71|12|383|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-72|12|384|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-73|12|390|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-74|12|417|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-75|12|420|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-76|12|441|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-77|12|445|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-78|12|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-79|12|468|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-80|12|470|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-81|12|489|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-82|12|507|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-83|12|507|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-84|12|517|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-85|12|523|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-86|12|532|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-87|12|543|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-88|12|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-89|12|553|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-90|12|572|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-91|12|573|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-92|12|644|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-93|12|682|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-94|12|696|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-95|12|713|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-96|12|714|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-97|12|749|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|1| 84|X-rays whole body|1100|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-98|12|763|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-1|12|62|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-2|12|67|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-3|12|69|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-4|12|70|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-5|12|72|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-6|12|73|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-7|12|76|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-8|12|76|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-9|12|78|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-10|12|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-11|12|90|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-12|12|94|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-13|12|95|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-14|12|105|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-15|12|112|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-16|12|119|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-17|12|121|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-18|12|123|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-19|12|128|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-20|12|135|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-21|12|137|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-22|12|139|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-23|12|139|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-24|12|143|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-25|12|144|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-26|12|152|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-27|12|152|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-28|12|153|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-29|12|156|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-30|12|164|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-31|12|164|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-32|12|167|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-33|12|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-34|12|183|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-35|12|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-36|12|191|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-37|12|193|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-38|12|200|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-39|12|202|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-40|12|202|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-41|12|204|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-42|12|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-43|12|216|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-44|12|218|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-45|12|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-46|12|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-47|12|225|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-48|12|234|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-49|12|237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-50|12|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-51|12|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-52|12|243|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-53|12|243|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-54|12|245|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-55|12|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-56|12|248|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-57|12|294|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-58|12|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-59|12|295|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-60|12|298|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-61|12|299|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-62|12|307|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-63|12|317|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-64|12|343|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-65|12|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-66|12|352|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-67|12|353|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-68|12|355|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-69|12|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-70|12|378|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-71|12|383|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-72|12|384|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-73|12|390|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-74|12|417|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-75|12|420|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-76|12|441|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-77|12|445|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-78|12|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-79|12|468|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-80|12|470|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-81|12|489|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-82|12|507|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-83|12|507|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-84|12|517|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-85|12|523|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-86|12|532|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-87|12|543|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-88|12|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-89|12|553|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-90|12|572|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-91|12|573|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-92|12|644|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-93|12|682|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-94|12|696|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-95|12|713|Other deterministic changes|Lower respiratory system|n/a|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-96|12|714|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-97|12|749|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-12|XBA-Gy 11,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|98 (98 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-12-98|12|763|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-1|13|65|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-2|13|66|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-3|13|70|Other deterministic changes|Whole body|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-4|13|75|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-5|13|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-6|13|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-7|13|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-8|13|82|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-9|13|85|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-10|13|95|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-11|13|98|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-12|13|101|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-13|13|102|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-14|13|106|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-15|13|108|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-16|13|113|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-17|13|117|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-18|13|118|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-19|13|129|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-20|13|149|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-21|13|150|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-22|13|151|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-23|13|153|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-24|13|158|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-25|13|170|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-26|13|173|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-27|13|181|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-28|13|184|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-29|13|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-30|13|248|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-31|13|303|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-32|13|303|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-33|13|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-34|13|349|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-35|13|474|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-36|13|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-37|13|621|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-1|13|65|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-2|13|66|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-3|13|70|Other deterministic changes|Whole body|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-4|13|75|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-5|13|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-6|13|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-7|13|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-8|13|82|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-9|13|85|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-10|13|95|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-11|13|98|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-12|13|101|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-13|13|102|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-14|13|106|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-15|13|108|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-16|13|113|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-17|13|117|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-18|13|118|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-19|13|129|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-20|13|149|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-21|13|150|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-22|13|151|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-23|13|153|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-24|13|158|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-25|13|170|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-26|13|173|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-27|13|181|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-28|13|184|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-29|13|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-30|13|248|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-31|13|303|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-32|13|303|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-33|13|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-34|13|349|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-35|13|474|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-36|13|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-13|XBA-Gy 12,n/a|2| 84|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|37 (37 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-13-37|13|621|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-1|14|123|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-2|14|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-3|14|181|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-4|14|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-5|14|296|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-6|14|383|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-7|14|414|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-8|14|421|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-9|14|432|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-10|14|495|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-11|14|499|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-12|14|522|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-13|14|522|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-14|14|533|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-15|14|535|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-16|14|537|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-17|14|547|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-18|14|560|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-19|14|572|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-20|14|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-21|14|598|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-22|14|606|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-23|14|607|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-24|14|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-25|14|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-26|14|622|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-27|14|656|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-28|14|657|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-29|14|659|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-30|14|663|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-31|14|668|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-32|14|669|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-33|14|674|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-34|14|683|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-35|14|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-36|14|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-37|14|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-38|14|697|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-39|14|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-40|14|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-41|14|705|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-42|14|708|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-43|14|715|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-44|14|720|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-45|14|722|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-46|14|726|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-47|14|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-48|14|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-49|14|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-50|14|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-51|14|742|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-52|14|747|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-53|14|750|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-54|14|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-55|14|762|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-56|14|762|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-57|14|763|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-58|14|763|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-59|14|765|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-60|14|765|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-61|14|768|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-62|14|769|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-63|14|769|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-64|14|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-65|14|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-66|14|774|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-67|14|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-68|14|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-69|14|781|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-70|14|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-71|14|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-72|14|783|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-73|14|784|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-74|14|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-75|14|787|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-76|14|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-77|14|791|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-78|14|792|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-79|14|793|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-80|14|794|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-81|14|801|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-82|14|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-83|14|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-84|14|817|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-85|14|822|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-86|14|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-87|14|828|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-88|14|839|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-89|14|846|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-90|14|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-91|14|855|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-92|14|864|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-93|14|865|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-94|14|870|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-95|14|871|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-96|14|875|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-97|14|880|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-98|14|881|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-99|14|885|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-100|14|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-101|14|888|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-102|14|891|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-103|14|895|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-104|14|896|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-105|14|899|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-106|14|900|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-107|14|902|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-108|14|905|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-109|14|910|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-110|14|912|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-111|14|913|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-112|14|916|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-113|14|917|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-114|14|919|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-115|14|921|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-116|14|921|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-117|14|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-118|14|923|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-119|14|926|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-120|14|926|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-121|14|928|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-122|14|929|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-123|14|930|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-124|14|933|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-125|14|937|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-126|14|937|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-127|14|938|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-128|14|941|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-129|14|944|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-130|14|950|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-131|14|952|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-132|14|958|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-133|14|962|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-134|14|966|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-135|14|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-136|14|986|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-137|14|995|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-138|14|1012|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-139|14|1034|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-140|14|1035|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-141|14|1045|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-142|14|1047|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-143|14|1057|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-144|14|1091|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|1| 84|X-rays whole body|100|roentgens|External exposure| whole body single|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-145|14|1098|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-1|14|123|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-2|14|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-3|14|181|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-4|14|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-5|14|296|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-6|14|383|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-7|14|414|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-8|14|421|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-9|14|432|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-10|14|495|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-11|14|499|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-12|14|522|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-13|14|522|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-14|14|533|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-15|14|535|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-16|14|537|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-17|14|547|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-18|14|560|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-19|14|572|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-20|14|589|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-21|14|598|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-22|14|606|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-23|14|607|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-24|14|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-25|14|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-26|14|622|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-27|14|656|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-28|14|657|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-29|14|659|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-30|14|663|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-31|14|668|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-32|14|669|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-33|14|674|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-34|14|683|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-35|14|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-36|14|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-37|14|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-38|14|697|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-39|14|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-40|14|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-41|14|705|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-42|14|708|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-43|14|715|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-44|14|720|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-45|14|722|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-46|14|726|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-47|14|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-48|14|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-49|14|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-50|14|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-51|14|742|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-52|14|747|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-53|14|750|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-54|14|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-55|14|762|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-56|14|762|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-57|14|763|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-58|14|763|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-59|14|765|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-60|14|765|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-61|14|768|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-62|14|769|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-63|14|769|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-64|14|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-65|14|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-66|14|774|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-67|14|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-68|14|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-69|14|781|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-70|14|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-71|14|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-72|14|783|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-73|14|784|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-74|14|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-75|14|787|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-76|14|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-77|14|791|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-78|14|792|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-79|14|793|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-80|14|794|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-81|14|801|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-82|14|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-83|14|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-84|14|817|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-85|14|822|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-86|14|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-87|14|828|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-88|14|839|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-89|14|846|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-90|14|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-91|14|855|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-92|14|864|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-93|14|865|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-94|14|870|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-95|14|871|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-96|14|875|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-97|14|880|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-98|14|881|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-99|14|885|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-100|14|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-101|14|888|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-102|14|891|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-103|14|895|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-104|14|896|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-105|14|899|Other deterministic changes|Whole body|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-106|14|900|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-107|14|902|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-108|14|905|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-109|14|910|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-110|14|912|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-111|14|913|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-112|14|916|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-113|14|917|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-114|14|919|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-115|14|921|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-116|14|921|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-117|14|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-118|14|923|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-119|14|926|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-120|14|926|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-121|14|928|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-122|14|929|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-123|14|930|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-124|14|933|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-125|14|937|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-126|14|937|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-127|14|938|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-128|14|941|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-129|14|944|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-130|14|950|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-131|14|952|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-132|14|958|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-133|14|962|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-134|14|966|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-135|14|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-136|14|986|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-137|14|995|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-138|14|1012|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-139|14|1034|Other deterministic changes|Lower respiratory system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-140|14|1035|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-141|14|1045|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-142|14|1047|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-143|14|1057|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-144|14|1091|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-14|XBM-Gy 1,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|145 (145 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-14-145|14|1098|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-1|15|65|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-2|15|113|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-3|15|122|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-4|15|197|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-5|15|210|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-6|15|290|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-7|15|336|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-8|15|355|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-9|15|376|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-10|15|418|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-11|15|432|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-12|15|440|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-13|15|451|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-14|15|461|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-15|15|482|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-16|15|489|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-17|15|494|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-18|15|516|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-19|15|522|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-20|15|546|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-21|15|553|Other deterministic changes|Whole body|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-22|15|573|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-23|15|579|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-24|15|589|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-25|15|593|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-26|15|593|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-27|15|594|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-28|15|627|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-29|15|631|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-30|15|638|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-31|15|640|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-32|15|641|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-33|15|646|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-34|15|646|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-35|15|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-36|15|650|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-37|15|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-38|15|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-39|15|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-40|15|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-41|15|682|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-42|15|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-43|15|689|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-44|15|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-45|15|695|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-46|15|696|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-47|15|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-48|15|700|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-49|15|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-50|15|707|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-51|15|713|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-52|15|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-53|15|719|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-54|15|719|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-55|15|729|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-56|15|734|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-57|15|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-58|15|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-59|15|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-60|15|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-61|15|756|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-62|15|759|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-63|15|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-64|15|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-65|15|773|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-66|15|775|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-67|15|777|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-68|15|777|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-69|15|781|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-70|15|782|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-71|15|793|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-72|15|798|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-73|15|801|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-74|15|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-75|15|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-76|15|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-77|15|826|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-78|15|826|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-79|15|827|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-80|15|827|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-81|15|840|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-82|15|841|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-83|15|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-84|15|846|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-85|15|847|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-86|15|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-87|15|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-88|15|854|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-89|15|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-90|15|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-91|15|869|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-92|15|869|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-93|15|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-94|15|875|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-95|15|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-96|15|876|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-97|15|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-98|15|879|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-99|15|880|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-100|15|880|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-101|15|881|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-102|15|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-103|15|883|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-104|15|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-105|15|887|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-106|15|890|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-107|15|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-108|15|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-109|15|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-110|15|895|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-111|15|896|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-112|15|897|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-113|15|898|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-114|15|912|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-115|15|912|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-116|15|915|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-117|15|918|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-118|15|926|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-119|15|928|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-120|15|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-121|15|941|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-122|15|942|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-123|15|943|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-124|15|947|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-125|15|959|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-126|15|967|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-127|15|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-128|15|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-129|15|991|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-130|15|1009|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-131|15|1009|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-132|15|1010|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-133|15|1019|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-134|15|1038|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-135|15|1056|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|1| 84|X-rays whole body|175|roentgens|External exposure| whole body single|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-136|15|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-1|15|65|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-2|15|113|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-3|15|122|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-4|15|197|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-5|15|210|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-6|15|290|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-7|15|336|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-8|15|355|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-9|15|376|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-10|15|418|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-11|15|432|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-12|15|440|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-13|15|451|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-14|15|461|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-15|15|482|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-16|15|489|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-17|15|494|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-18|15|516|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-19|15|522|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-20|15|546|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-21|15|553|Other deterministic changes|Whole body|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-22|15|573|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-23|15|579|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-24|15|589|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-25|15|593|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-26|15|593|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-27|15|594|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-28|15|627|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-29|15|631|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-30|15|638|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-31|15|640|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-32|15|641|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-33|15|646|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-34|15|646|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-35|15|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-36|15|650|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-37|15|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-38|15|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-39|15|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-40|15|663|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-41|15|682|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-42|15|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-43|15|689|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-44|15|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-45|15|695|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-46|15|696|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-47|15|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-48|15|700|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-49|15|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-50|15|707|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-51|15|713|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-52|15|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-53|15|719|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-54|15|719|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-55|15|729|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-56|15|734|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-57|15|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-58|15|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-59|15|749|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-60|15|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-61|15|756|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-62|15|759|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-63|15|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-64|15|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-65|15|773|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-66|15|775|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-67|15|777|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-68|15|777|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-69|15|781|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-70|15|782|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-71|15|793|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-72|15|798|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-73|15|801|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-74|15|806|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-75|15|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-76|15|826|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-77|15|826|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-78|15|826|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-79|15|827|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-80|15|827|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-81|15|840|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-82|15|841|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-83|15|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-84|15|846|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-85|15|847|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-86|15|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-87|15|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-88|15|854|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-89|15|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-90|15|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-91|15|869|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-92|15|869|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-93|15|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-94|15|875|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-95|15|875|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-96|15|876|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-97|15|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-98|15|879|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-99|15|880|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-100|15|880|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-101|15|881|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-102|15|882|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-103|15|883|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-104|15|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-105|15|887|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-106|15|890|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-107|15|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-108|15|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-109|15|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-110|15|895|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-111|15|896|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-112|15|897|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-113|15|898|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-114|15|912|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-115|15|912|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-116|15|915|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-117|15|918|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-118|15|926|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-119|15|928|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-120|15|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-121|15|941|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-122|15|942|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-123|15|943|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-124|15|947|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-125|15|959|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-126|15|967|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-127|15|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-128|15|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-129|15|991|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-130|15|1009|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-131|15|1009|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-132|15|1010|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-133|15|1019|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-134|15|1038|Other deterministic changes|Lower respiratory system|n/a|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-135|15|1056|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-15|XBM-Gy 1.75,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|136 (136 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-15-136|15|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-1|16|126|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-2|16|133|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-3|16|346|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-4|16|354|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-5|16|383|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-6|16|390|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-7|16|391|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-8|16|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-9|16|432|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-10|16|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-11|16|452|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-12|16|470|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-13|16|473|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-14|16|474|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-15|16|476|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-16|16|489|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-17|16|491|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-18|16|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-19|16|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-20|16|499|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-21|16|508|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-22|16|517|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-23|16|529|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-24|16|529|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-25|16|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-26|16|551|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-27|16|556|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-28|16|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-29|16|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-30|16|581|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-31|16|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-32|16|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-33|16|592|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-34|16|608|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-35|16|627|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-36|16|629|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-37|16|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-38|16|633|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-39|16|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-40|16|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-41|16|640|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-42|16|640|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-43|16|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-44|16|651|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-45|16|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-46|16|665|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-47|16|675|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-48|16|683|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-49|16|687|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-50|16|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-51|16|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-52|16|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-53|16|702|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-54|16|705|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-55|16|710|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-56|16|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-57|16|728|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-58|16|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-59|16|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-60|16|748|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-61|16|751|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-62|16|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-63|16|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-64|16|756|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-65|16|757|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-66|16|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-67|16|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-68|16|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-69|16|801|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-70|16|810|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-71|16|811|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-72|16|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-73|16|816|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-74|16|830|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-75|16|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-76|16|833|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-77|16|847|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-78|16|849|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-79|16|849|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-80|16|857|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-81|16|859|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-82|16|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-83|16|883|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-84|16|889|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-85|16|895|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-86|16|903|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-87|16|904|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-88|16|945|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-89|16|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-90|16|1018|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|1| 84|X-rays whole body|350|roentgens|External exposure| whole body single|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-91|16|1076|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-1|16|126|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-2|16|133|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-3|16|346|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-4|16|354|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-5|16|383|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-6|16|390|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-7|16|391|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-8|16|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-9|16|432|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-10|16|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-11|16|452|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-12|16|470|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-13|16|473|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-14|16|474|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-15|16|476|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-16|16|489|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-17|16|491|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-18|16|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-19|16|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-20|16|499|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-21|16|508|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-22|16|517|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-23|16|529|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-24|16|529|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-25|16|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-26|16|551|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-27|16|556|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-28|16|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-29|16|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-30|16|581|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-31|16|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-32|16|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-33|16|592|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-34|16|608|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-35|16|627|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-36|16|629|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-37|16|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-38|16|633|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-39|16|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-40|16|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-41|16|640|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-42|16|640|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-43|16|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-44|16|651|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-45|16|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-46|16|665|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-47|16|675|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-48|16|683|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-49|16|687|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-50|16|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-51|16|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-52|16|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-53|16|702|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-54|16|705|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-55|16|710|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-56|16|711|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-57|16|728|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-58|16|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-59|16|738|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-60|16|748|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-61|16|751|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-62|16|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-63|16|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-64|16|756|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-65|16|757|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-66|16|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-67|16|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-68|16|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-69|16|801|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-70|16|810|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-71|16|811|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-72|16|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-73|16|816|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-74|16|830|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-75|16|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-76|16|833|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-77|16|847|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-78|16|849|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-79|16|849|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-80|16|857|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-81|16|859|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-82|16|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-83|16|883|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-84|16|889|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-85|16|895|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-86|16|903|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-87|16|904|Other deterministic changes|Lower respiratory system|n/a|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-88|16|945|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-89|16|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-90|16|1018|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-16|XBM-Gy 3.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|91 (91 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-16-91|16|1076|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-17|XBM-Gy 5,n/a|Sequence:1, Age:84,Type:X-rays whole body,Quantity:500,Unit:roentgens,Application:External exposure, Remarks:n/a|164 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|n/a|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-17|XBM-Gy 5,n/a|Sequence:2, Age:84,Type:Mix AET, 5HT, MEA, glutathion,Quantity:,Unit:milligrams per animal,Application:Injection, intraperitoneal, Remarks:8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|164 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|n/a|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-1|18|66|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-2|18|74|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-3|18|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-4|18|110|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-5|18|149|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-6|18|195|Other deterministic changes|Whole body|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-7|18|200|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-8|18|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-9|18|218|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-10|18|230|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-11|18|274|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-12|18|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-13|18|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-14|18|312|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-15|18|314|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-16|18|321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-17|18|323|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-18|18|342|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-19|18|347|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-20|18|360|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-21|18|379|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-22|18|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-23|18|382|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-24|18|387|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-25|18|389|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-26|18|402|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-27|18|407|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-28|18|432|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-29|18|433|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-30|18|433|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-31|18|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-32|18|481|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-33|18|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-34|18|495|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-35|18|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-36|18|503|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-37|18|515|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-38|18|517|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-39|18|524|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-40|18|533|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-41|18|537|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-42|18|538|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-43|18|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-44|18|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-45|18|542|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-46|18|554|Other deterministic changes|Whole body|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-47|18|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-48|18|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-49|18|568|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-50|18|571|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-51|18|577|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-52|18|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-53|18|583|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-54|18|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-55|18|585|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-56|18|594|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-57|18|606|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-58|18|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-59|18|619|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-60|18|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-61|18|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-62|18|626|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-63|18|634|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-64|18|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-65|18|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-66|18|637|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-67|18|689|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-68|18|646|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-69|18|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-70|18|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-71|18|689|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-72|18|696|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-73|18|697|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-74|18|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-75|18|700|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-76|18|701|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-77|18|706|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-78|18|707|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-79|18|707|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-80|18|708|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-81|18|720|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-82|18|740|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-83|18|742|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-84|18|750|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-85|18|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-86|18|756|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-87|18|756|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-88|18|761|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-89|18|780|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-90|18|784|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-91|18|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-92|18|795|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-93|18|797|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-94|18|800|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-95|18|805|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-96|18|807|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-97|18|809|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-98|18|814|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-99|18|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-100|18|819|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-101|18|826|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-102|18|836|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-103|18|839|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-104|18|840|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-105|18|841|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-106|18|846|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-107|18|851|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-108|18|856|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-109|18|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-110|18|856|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-111|18|858|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-112|18|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-113|18|863|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-114|18|864|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-115|18|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-116|18|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-117|18|879|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-118|18|879|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-119|18|886|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-120|18|890|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-121|18|906|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-122|18|913|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-123|18|920|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-124|18|924|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-125|18|927|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-126|18|941|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-127|18|948|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-128|18|968|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-129|18|994|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|1| 84|X-rays whole body|650|roentgens|External exposure| whole body single|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-130|18|1064|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-1|18|66|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-2|18|74|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-3|18|81|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-4|18|110|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-5|18|149|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-6|18|195|Other deterministic changes|Whole body|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-7|18|200|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-8|18|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-9|18|218|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-10|18|230|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-11|18|274|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-12|18|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-13|18|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-14|18|312|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-15|18|314|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-16|18|321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-17|18|323|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-18|18|342|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-19|18|347|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-20|18|360|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-21|18|379|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-22|18|380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-23|18|382|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-24|18|387|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-25|18|389|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-26|18|402|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-27|18|407|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-28|18|432|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-29|18|433|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-30|18|433|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-31|18|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-32|18|481|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-33|18|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-34|18|495|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-35|18|503|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-36|18|503|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-37|18|515|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-38|18|517|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-39|18|524|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-40|18|533|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-41|18|537|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-42|18|538|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-43|18|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-44|18|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-45|18|542|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-46|18|554|Other deterministic changes|Whole body|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-47|18|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-48|18|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-49|18|568|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-50|18|571|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-51|18|577|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-52|18|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-53|18|583|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-54|18|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-55|18|585|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-56|18|594|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-57|18|606|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-58|18|617|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-59|18|619|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-60|18|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-61|18|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-62|18|626|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-63|18|634|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-64|18|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-65|18|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-66|18|637|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-67|18|689|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-68|18|646|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-69|18|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-70|18|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-71|18|689|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-72|18|696|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-73|18|697|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-74|18|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-75|18|700|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-76|18|701|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-77|18|706|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-78|18|707|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-79|18|707|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-80|18|708|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-81|18|720|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-82|18|740|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-83|18|742|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-84|18|750|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-85|18|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-86|18|756|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-87|18|756|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-88|18|761|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-89|18|780|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-90|18|784|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-91|18|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-92|18|795|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-93|18|797|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-94|18|800|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-95|18|805|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-96|18|807|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-97|18|809|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-98|18|814|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-99|18|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-100|18|819|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-101|18|826|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-102|18|836|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-103|18|839|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-104|18|840|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-105|18|841|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-106|18|846|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-107|18|851|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-108|18|856|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-109|18|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-110|18|856|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-111|18|858|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-112|18|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-113|18|863|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-114|18|864|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-115|18|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-116|18|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-117|18|879|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-118|18|879|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-119|18|886|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-120|18|890|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-121|18|906|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-122|18|913|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-123|18|920|Other deterministic changes|Lower respiratory system|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-124|18|924|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-125|18|927|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-126|18|941|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-127|18|948|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-128|18|968|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-129|18|994|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-18|XBM-Gy 6.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|130 (130 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-18-130|18|1064|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-1|19|87|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-2|19|106|Other deterministic changes|Whole body|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-3|19|118|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-4|19|138|Other deterministic changes|Whole body|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-5|19|147|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-6|19|148|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-7|19|162|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-8|19|164|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-9|19|190|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-10|19|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-11|19|207|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-12|19|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-13|19|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-14|19|262|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-15|19|278|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-16|19|291|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-17|19|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-18|19|319|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-19|19|333|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-20|19|384|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-21|19|389|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-22|19|397|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-23|19|403|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-24|19|406|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-25|19|426|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-26|19|439|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-27|19|480|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-28|19|485|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-29|19|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-30|19|501|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-31|19|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-32|19|505|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-33|19|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-34|19|524|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-35|19|527|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-36|19|529|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-37|19|532|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-38|19|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-39|19|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-40|19|543|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-41|19|544|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-42|19|553|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-43|19|555|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-44|19|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-45|19|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-46|19|559|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-47|19|561|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-48|19|580|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-49|19|582|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-50|19|586|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-51|19|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-52|19|589|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-53|19|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-54|19|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-55|19|602|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-56|19|602|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-57|19|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-58|19|615|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-59|19|617|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-60|19|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-61|19|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-62|19|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-63|19|641|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-64|19|662|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-65|19|666|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-66|19|667|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-67|19|669|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-68|19|673|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-69|19|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-70|19|682|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-71|19|683|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-72|19|686|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-73|19|703|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-74|19|705|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-75|19|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-76|19|708|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-77|19|709|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-78|19|712|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-79|19|718|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-80|19|720|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-81|19|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-82|19|748|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-83|19|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-84|19|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-85|19|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-86|19|756|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-87|19|760|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-88|19|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|1| 84|X-rays whole body|1000|roentgens|External exposure| whole body single|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-89|19|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-1|19|87|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-2|19|106|Other deterministic changes|Whole body|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-3|19|118|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-4|19|138|Other deterministic changes|Whole body|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-5|19|147|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-6|19|148|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-7|19|162|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-8|19|164|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-9|19|190|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-10|19|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-11|19|207|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-12|19|213|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-13|19|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-14|19|262|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-15|19|278|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-16|19|291|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-17|19|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-18|19|319|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-19|19|333|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-20|19|384|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-21|19|389|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-22|19|397|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-23|19|403|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-24|19|406|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-25|19|426|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-26|19|439|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-27|19|480|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-28|19|485|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-29|19|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-30|19|501|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-31|19|504|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-32|19|505|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-33|19|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-34|19|524|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-35|19|527|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-36|19|529|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-37|19|532|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-38|19|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-39|19|542|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-40|19|543|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-41|19|544|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-42|19|553|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-43|19|555|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-44|19|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-45|19|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-46|19|559|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-47|19|561|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-48|19|580|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-49|19|582|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-50|19|586|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-51|19|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-52|19|589|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-53|19|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-54|19|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-55|19|602|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-56|19|602|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-57|19|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-58|19|615|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-59|19|617|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-60|19|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-61|19|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-62|19|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-63|19|641|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-64|19|662|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-65|19|666|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-66|19|667|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-67|19|669|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-68|19|673|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-69|19|678|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-70|19|682|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-71|19|683|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-72|19|686|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-73|19|703|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-74|19|705|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-75|19|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-76|19|708|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-77|19|709|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-78|19|712|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-79|19|718|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-80|19|720|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-81|19|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-82|19|748|Other deterministic changes|Lower respiratory system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-83|19|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-84|19|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-85|19|748|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-86|19|756|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-87|19|760|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-88|19|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-19|XBM-Gy 10,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|89 (89 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-19-89|19|819|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-1|20|76|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-2|20|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-3|20|90|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-4|20|107|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-5|20|109|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-6|20|120|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-7|20|122|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-8|20|136|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-9|20|136|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-10|20|144|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-11|20|157|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-12|20|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-13|20|168|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-14|20|186|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-15|20|192|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-16|20|194|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-17|20|199|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-18|20|224|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-19|20|257|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-20|20|257|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-21|20|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-22|20|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-23|20|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-24|20|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-25|20|265|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-26|20|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-27|20|280|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-28|20|290|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-29|20|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-30|20|297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-31|20|312|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-32|20|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-33|20|329|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-34|20|336|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-35|20|338|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-36|20|348|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-37|20|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-38|20|356|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-39|20|357|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-40|20|376|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-41|20|382|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-42|20|385|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-43|20|387|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-44|20|390|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-45|20|397|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-46|20|400|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-47|20|408|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-48|20|439|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-49|20|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-50|20|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-51|20|461|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-52|20|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-53|20|530|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-54|20|531|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-55|20|549|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-56|20|560|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-57|20|574|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-58|20|575|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-59|20|579|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-60|20|579|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-61|20|587|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-62|20|589|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-63|20|590|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-64|20|592|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-65|20|594|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-66|20|607|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-67|20|609|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-68|20|610|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-69|20|617|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-70|20|640|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-71|20|646|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-72|20|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-73|20|666|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-74|20|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-75|20|702|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-76|20|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-77|20|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-78|20|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-79|20|755|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-80|20|758|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|1| 84|X-rays whole body|1200|roentgens|External exposure| whole body single|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-81|20|794|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-1|20|76|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-2|20|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-3|20|90|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-4|20|107|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-5|20|109|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-6|20|120|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-7|20|122|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-8|20|136|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-9|20|136|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-10|20|144|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-11|20|157|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-12|20|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-13|20|168|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-14|20|186|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-15|20|192|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-16|20|194|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-17|20|199|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-18|20|224|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-19|20|257|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-20|20|257|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-21|20|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-22|20|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-23|20|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-24|20|264|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-25|20|265|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-26|20|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-27|20|280|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-28|20|290|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-29|20|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-30|20|297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-31|20|312|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-32|20|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-33|20|329|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-34|20|336|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-35|20|338|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-36|20|348|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-37|20|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-38|20|356|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-39|20|357|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-40|20|376|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-41|20|382|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-42|20|385|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-43|20|387|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-44|20|390|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-45|20|397|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-46|20|400|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-47|20|408|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-48|20|439|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-49|20|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-50|20|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-51|20|461|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-52|20|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-53|20|530|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-54|20|531|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-55|20|549|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-56|20|560|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-57|20|574|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-58|20|575|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-59|20|579|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-60|20|579|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-61|20|587|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-62|20|589|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-63|20|590|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-64|20|592|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-65|20|594|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-66|20|607|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-67|20|609|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-68|20|610|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-69|20|617|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-70|20|640|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-71|20|646|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-72|20|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-73|20|666|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-74|20|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-75|20|702|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-76|20|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-77|20|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-78|20|734|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-79|20|755|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-80|20|758|Other deterministic changes|Lower respiratory system|n/a|
9-4-20|XBM-Gy 12,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|81 (81 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-20-81|20|794|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-1|21|69|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-2|21|74|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-3|21|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-4|21|78|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-5|21|83|Other deterministic changes|Whole body|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-6|21|86|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-7|21|89|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-8|21|90|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-9|21|101|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-10|21|107|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-11|21|111|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-12|21|112|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-13|21|114|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-14|21|117|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-15|21|119|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-16|21|129|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-17|21|144|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-18|21|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-19|21|184|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-20|21|188|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-21|21|194|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-22|21|227|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-23|21|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-24|21|260|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-25|21|265|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-26|21|294|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-27|21|303|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-28|21|309|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-29|21|313|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-30|21|343|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-31|21|355|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-32|21|394|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-33|21|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-34|21|518|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-35|21|594|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-36|21|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-37|21|662|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-38|21|707|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-39|21|724|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|1| 84|X-rays whole body|1350|roentgens|External exposure| whole body single|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-40|21|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-1|21|69|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-2|21|74|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-3|21|77|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-4|21|78|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-5|21|83|Other deterministic changes|Whole body|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-6|21|86|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-7|21|89|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-8|21|90|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-9|21|101|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-10|21|107|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-11|21|111|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-12|21|112|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-13|21|114|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-14|21|117|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-15|21|119|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-16|21|129|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-17|21|144|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-18|21|159|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-19|21|184|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-20|21|188|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-21|21|194|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-22|21|227|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-23|21|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-24|21|260|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-25|21|265|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-26|21|294|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-27|21|303|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-28|21|309|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-29|21|313|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-30|21|343|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-31|21|355|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-32|21|394|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-33|21|406|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-34|21|518|Other deterministic changes|Lower respiratory system|n/a|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-35|21|594|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-36|21|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-37|21|662|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-38|21|707|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-39|21|724|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-21|XBM-Gy 13.5,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|40 (40 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|9-4-21-40|21|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-22|XBH-Gy 5.5,n/a|Sequence:1, Age:84,Type:X-rays whole body,Quantity:650,Unit:roentgens,Application:External exposure, Remarks:whole body single|89 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-22|XBH-Gy 5.5,n/a|Sequence:2, Age:84,Type:serotonin,Quantity:1,Unit:milligrams per animal,Application:Injection, intraperitoneal, Remarks:n/a|89 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-23|XBH-Gy 10,n/a|Sequence:1, Age:84,Type:X-rays whole body,Quantity:1000,Unit:roentgens,Application:External exposure, Remarks:whole body single|56 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-23|XBH-Gy 10,n/a|Sequence:2, Age:84,Type:serotonin,Quantity:1,Unit:milligrams per animal,Application:Injection, intraperitoneal, Remarks:n/a|56 (0 in ERA)|Mouse|Mouse, C57BL/6Bd|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-1|24|88|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-2|24|203|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-3|24|279|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-4|24|442|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-5|24|449|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-6|24|467|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-7|24|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-8|24|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-9|24|495|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-10|24|516|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-11|24|528|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-12|24|567|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-13|24|574|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-14|24|577|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-15|24|578|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-16|24|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-17|24|594|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-18|24|598|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-19|24|603|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-20|24|605|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-21|24|609|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-22|24|622|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-23|24|623|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-24|24|624|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-25|24|629|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-26|24|629|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-27|24|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-28|24|634|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-29|24|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-30|24|650|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-31|24|650|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-32|24|651|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-33|24|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-34|24|657|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-35|24|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-36|24|665|Other deterministic changes|Whole body|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-37|24|666|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-38|24|675|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-39|24|676|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-40|24|678|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-41|24|678|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-42|24|681|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-43|24|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-44|24|684|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-45|24|684|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-46|24|686|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-47|24|688|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-48|24|694|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-49|24|694|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-50|24|695|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-51|24|697|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-52|24|698|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-53|24|702|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-54|24|702|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-55|24|703|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-56|24|704|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-57|24|704|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-58|24|705|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-59|24|709|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-60|24|710|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-61|24|711|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-62|24|712|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-63|24|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-64|24|716|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-65|24|719|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-66|24|721|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-67|24|721|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-68|24|722|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-69|24|722|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-70|24|724|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-71|24|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-72|24|728|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-73|24|728|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-74|24|729|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-75|24|729|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-76|24|729|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-77|24|730|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-78|24|732|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-79|24|735|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-80|24|735|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-81|24|739|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-82|24|743|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-83|24|746|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-84|24|747|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-85|24|749|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-86|24|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-87|24|756|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-88|24|758|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-89|24|758|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-90|24|758|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-91|24|762|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-92|24|762|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-93|24|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-94|24|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-95|24|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-96|24|775|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-97|24|775|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-98|24|777|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-99|24|780|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-100|24|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-101|24|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-102|24|783|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-103|24|783|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-104|24|784|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-105|24|787|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-106|24|787|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-107|24|788|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-108|24|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-109|24|789|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-110|24|791|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-111|24|795|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-112|24|796|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-113|24|797|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-114|24|799|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-115|24|802|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-116|24|804|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-117|24|807|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-118|24|809|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-119|24|811|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-120|24|820|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-121|24|830|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-122|24|831|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-123|24|837|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-124|24|839|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-125|24|842|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-126|24|845|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-127|24|852|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-128|24|860|Other deterministic changes|Lower respiratory system|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-129|24|864|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-130|24|872|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-24|XC-Gy 0,n/a|1| 28|none (controls)|0|unit code not relevant|not applicable or not supplied| n/a|131 (131 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-24-131|24|873|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-1|25|119|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-2|25|121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-3|25|131|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-4|25|149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-5|25|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-6|25|158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-7|25|165|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-8|25|178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-9|25|183|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-10|25|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-11|25|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-12|25|194|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-13|25|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-14|25|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-15|25|205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-16|25|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-17|25|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-18|25|216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-19|25|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-20|25|233|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-21|25|234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-22|25|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-23|25|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-24|25|254|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-25|25|256|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-26|25|273|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-27|25|283|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-28|25|302|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-29|25|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-30|25|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-31|25|395|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-32|25|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-33|25|505|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-34|25|532|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-35|25|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-36|25|566|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-37|25|570|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-38|25|580|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-39|25|589|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-40|25|594|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-41|25|597|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-42|25|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-43|25|610|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-44|25|635|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-45|25|638|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-46|25|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-47|25|647|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-48|25|654|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-49|25|662|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-50|25|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-51|25|668|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-52|25|668|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-53|25|672|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-54|25|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-55|25|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-56|25|680|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-57|25|683|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-58|25|685|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-59|25|701|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-60|25|701|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-61|25|717|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-62|25|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-63|25|728|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-64|25|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-65|25|740|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-66|25|743|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-67|25|750|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-68|25|750|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-69|25|750|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-70|25|753|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-71|25|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-72|25|761|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-73|25|763|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-74|25|764|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-75|25|765|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-76|25|766|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-77|25|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-78|25|778|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-79|25|779|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-80|25|781|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-81|25|782|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-82|25|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-83|25|805|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-84|25|811|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-85|25|812|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-86|25|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-87|25|820|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-88|25|824|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-89|25|826|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-90|25|827|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-91|25|830|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-92|25|839|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-93|25|843|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-94|25|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-95|25|848|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-96|25|849|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-97|25|872|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-98|25|874|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-99|25|876|Other deterministic changes|Lower respiratory system|n/a|
9-4-25|C-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-25-100|25|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-1|26|115|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-2|26|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-3|26|132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-4|26|139|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-5|26|142|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-6|26|143|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-7|26|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-8|26|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-9|26|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-10|26|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-11|26|161|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-12|26|165|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-13|26|166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-14|26|168|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-15|26|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-16|26|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-17|26|178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-18|26|182|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-19|26|190|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-20|26|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-21|26|193|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-22|26|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-23|26|199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-24|26|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-25|26|204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-26|26|204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-27|26|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-28|26|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-29|26|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-30|26|225|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-31|26|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-32|26|229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-33|26|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-34|26|240|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-35|26|248|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-36|26|248|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-37|26|261|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-38|26|292|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-39|26|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-40|26|355|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-41|26|380|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-42|26|382|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-43|26|491|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-44|26|501|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-45|26|508|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-46|26|534|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-47|26|538|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-48|26|546|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-49|26|565|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-50|26|571|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-51|26|575|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-52|26|590|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-53|26|596|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-54|26|603|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-55|26|610|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-56|26|625|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-57|26|628|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-58|26|655|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-59|26|661|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-60|26|664|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-61|26|671|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-62|26|678|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-63|26|688|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-64|26|692|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-65|26|698|Other deterministic changes|Lower respiratory system|n/a|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-66|26|707|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-67|26|735|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-68|26|756|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-26|XC-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|69 (69 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-26-69|26|763|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-1|27|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-2|27|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-3|27|163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-4|27|166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-5|27|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-6|27|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-7|27|189|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-8|27|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-9|27|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-10|27|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-11|27|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-12|27|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-13|27|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-14|27|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-15|27|230|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-16|27|239|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-17|27|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-18|27|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-19|27|341|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-20|27|360|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-21|27|375|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-22|27|418|Other deterministic changes|Whole body|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-23|27|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-24|27|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-25|27|517|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-26|27|525|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-27|27|532|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-28|27|554|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-29|27|558|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-30|27|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-31|27|577|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-32|27|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-33|27|594|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-34|27|604|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-35|27|607|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-36|27|608|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-37|27|615|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-38|27|620|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-39|27|628|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-40|27|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-41|27|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-42|27|668|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-43|27|675|Other deterministic changes|Whole body|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-44|27|679|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-45|27|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-46|27|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-47|27|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-48|27|711|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-49|27|713|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-50|27|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-51|27|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-52|27|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-53|27|730|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-54|27|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-55|27|743|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-56|27|751|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-57|27|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-58|27|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-59|27|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-60|27|762|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-61|27|763|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-62|27|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-63|27|774|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-64|27|775|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-65|27|777|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-66|27|777|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-67|27|781|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-68|27|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-69|27|782|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-70|27|785|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-71|27|786|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-72|27|786|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-73|27|798|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-74|27|803|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-75|27|807|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-76|27|809|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-77|27|821|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-78|27|831|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-79|27|832|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-80|27|836|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-81|27|839|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-82|27|840|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-83|27|843|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-84|27|853|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-85|27|863|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-86|27|865|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-87|27|869|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-88|27|873|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-89|27|874|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-90|27|883|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-91|27|887|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-92|27|894|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-93|27|909|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-94|27|911|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-95|27|914|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-96|27|967|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-97|27|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|1| 28|X-rays whole body|350|roentgens|External exposure| whole body single|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-98|27|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-1|27|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-2|27|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-3|27|163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-4|27|166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-5|27|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-6|27|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-7|27|189|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-8|27|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-9|27|196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-10|27|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-11|27|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-12|27|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-13|27|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-14|27|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-15|27|230|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-16|27|239|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-17|27|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-18|27|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-19|27|341|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-20|27|360|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-21|27|375|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-22|27|418|Other deterministic changes|Whole body|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-23|27|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-24|27|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-25|27|517|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-26|27|525|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-27|27|532|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-28|27|554|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-29|27|558|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-30|27|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-31|27|577|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-32|27|579|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-33|27|594|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-34|27|604|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-35|27|607|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-36|27|608|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-37|27|615|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-38|27|620|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-39|27|628|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-40|27|629|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-41|27|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-42|27|668|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-43|27|675|Other deterministic changes|Whole body|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-44|27|679|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-45|27|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-46|27|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-47|27|694|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-48|27|711|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-49|27|713|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-50|27|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-51|27|727|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-52|27|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-53|27|730|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-54|27|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-55|27|743|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-56|27|751|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-57|27|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-58|27|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-59|27|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-60|27|762|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-61|27|763|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-62|27|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-63|27|774|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-64|27|775|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-65|27|777|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-66|27|777|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-67|27|781|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-68|27|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-69|27|782|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-70|27|785|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-71|27|786|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-72|27|786|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-73|27|798|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-74|27|803|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-75|27|807|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-76|27|809|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-77|27|821|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-78|27|831|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-79|27|832|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-80|27|836|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-81|27|839|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-82|27|840|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-83|27|843|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-84|27|853|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-85|27|863|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-86|27|865|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-87|27|869|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-88|27|873|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-89|27|874|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-90|27|883|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-91|27|887|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-92|27|894|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-93|27|909|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-94|27|911|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-95|27|914|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-96|27|967|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-97|27|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-27|XCA-Gy 3.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| ip inject.|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-27-98|27|968|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-1|28|117|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-2|28|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-3|28|132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-4|28|137|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-5|28|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-6|28|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-7|28|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-8|28|166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-9|28|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-10|28|179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-11|28|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-12|28|204|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-13|28|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-14|28|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-15|28|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-16|28|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-17|28|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-18|28|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-19|28|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-20|28|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-21|28|266|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-22|28|269|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-23|28|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-24|28|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-25|28|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-26|28|289|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-27|28|296|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-28|28|405|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-29|28|409|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-30|28|411|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-31|28|416|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-32|28|478|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-33|28|482|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-34|28|485|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-35|28|486|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-36|28|515|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-37|28|524|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-38|28|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-39|28|541|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-40|28|545|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-41|28|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-42|28|557|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-43|28|560|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-44|28|577|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-45|28|594|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-46|28|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-47|28|613|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-48|28|615|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-49|28|617|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-50|28|625|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-51|28|633|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-52|28|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-53|28|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-54|28|660|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-55|28|663|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-56|28|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-57|28|690|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-58|28|691|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-59|28|710|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-60|28|714|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-61|28|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-62|28|718|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-63|28|720|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-64|28|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-65|28|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-66|28|734|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-67|28|735|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-68|28|741|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-69|28|742|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-70|28|743|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-71|28|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-72|28|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-73|28|755|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-74|28|758|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-75|28|759|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-76|28|763|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-77|28|771|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-78|28|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-79|28|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-80|28|773|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-81|28|785|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-82|28|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-83|28|789|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-84|28|792|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-85|28|792|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-86|28|793|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-87|28|798|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-88|28|802|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-89|28|804|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-90|28|805|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-91|28|806|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-92|28|807|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-93|28|809|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-94|28|824|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-95|28|827|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|1| 28|X-rays whole body|650|roentgens|External exposure| whole body single|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-96|28|861|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-1|28|117|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-2|28|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-3|28|132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-4|28|137|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-5|28|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-6|28|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-7|28|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-8|28|166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-9|28|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-10|28|179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-11|28|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-12|28|204|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-13|28|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-14|28|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-15|28|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-16|28|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-17|28|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-18|28|258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-19|28|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-20|28|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-21|28|266|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-22|28|269|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-23|28|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-24|28|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-25|28|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-26|28|289|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-27|28|296|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-28|28|405|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-29|28|409|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-30|28|411|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-31|28|416|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-32|28|478|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-33|28|482|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-34|28|485|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-35|28|486|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-36|28|515|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-37|28|524|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-38|28|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-39|28|541|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-40|28|545|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-41|28|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-42|28|557|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-43|28|560|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-44|28|577|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-45|28|594|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-46|28|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-47|28|613|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-48|28|615|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-49|28|617|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-50|28|625|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-51|28|633|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-52|28|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-53|28|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-54|28|660|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-55|28|663|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-56|28|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-57|28|690|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-58|28|691|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-59|28|710|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-60|28|714|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-61|28|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-62|28|718|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-63|28|720|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-64|28|723|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-65|28|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-66|28|734|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-67|28|735|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-68|28|741|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-69|28|742|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-70|28|743|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-71|28|748|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-72|28|753|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-73|28|755|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-74|28|758|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-75|28|759|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-76|28|763|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-77|28|771|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-78|28|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-79|28|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-80|28|773|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-81|28|785|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-82|28|788|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-83|28|789|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-84|28|792|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-85|28|792|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-86|28|793|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-87|28|798|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-88|28|802|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-89|28|804|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-90|28|805|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-91|28|806|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-92|28|807|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-93|28|809|Other deterministic changes|Lower respiratory system|n/a|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-94|28|824|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-95|28|827|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-28|XCA-Gy 6.5,n/a|2| 28|AET|8|milligrams per animal|Injection, intraperitoneal| n/a|96 (96 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|9-4-28-96|28|861|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-1|29|42|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-2|29|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-3|29|317|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-4|29|370|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-5|29|435|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-6|29|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-7|29|517|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-8|29|524|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-9|29|539|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-10|29|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-11|29|552|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-12|29|565|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-13|29|569|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-14|29|570|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-15|29|571|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-16|29|585|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-17|29|590|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-18|29|596|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-19|29|603|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-20|29|604|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-21|29|605|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-22|29|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-23|29|630|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-24|29|637|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-25|29|640|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-26|29|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-27|29|644|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-28|29|647|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-29|29|650|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-30|29|650|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-31|29|650|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-32|29|652|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-33|29|652|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-34|29|656|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-35|29|657|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-36|29|658|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-37|29|665|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-38|29|669|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-39|29|673|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-40|29|675|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-41|29|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-42|29|683|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-43|29|685|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-44|29|688|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-45|29|695|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-46|29|700|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-47|29|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-48|29|718|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-49|29|727|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-50|29|730|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-51|29|731|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-52|29|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-53|29|738|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-54|29|739|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-55|29|740|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-56|29|743|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-57|29|749|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-58|29|751|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-59|29|752|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-60|29|756|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-61|29|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-62|29|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-63|29|761|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-64|29|764|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-65|29|768|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-66|29|771|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-67|29|773|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-68|29|774|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-69|29|776|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-70|29|778|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-71|29|779|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-72|29|779|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-73|29|780|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-74|29|780|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-75|29|784|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-76|29|788|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-77|29|789|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-78|29|796|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-79|29|802|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-80|29|803|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-81|29|811|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-82|29|813|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-83|29|815|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-84|29|816|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-85|29|816|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-86|29|817|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-87|29|818|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-88|29|823|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-89|29|829|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-90|29|835|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-91|29|847|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-92|29|850|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-93|29|856|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-94|29|856|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-95|29|864|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-96|29|866|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-97|29|867|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-98|29|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-99|29|893|Other deterministic changes|Whole body|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-100|29|899|Other deterministic changes|Lower respiratory system|n/a|
9-4-29|XfC-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|101 (101 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|52 for pathol.|9-4-29-101|29|982|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-1|30|117|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-2|30|137|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-3|30|143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-4|30|151|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-5|30|152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-6|30|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-7|30|155|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-8|30|155|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-9|30|156|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-10|30|158|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-11|30|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-12|30|161|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-13|30|161|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-14|30|164|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-15|30|169|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-16|30|177|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-17|30|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-18|30|194|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-19|30|203|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-20|30|207|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-21|30|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-22|30|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-23|30|221|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-24|30|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-25|30|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-26|30|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-27|30|251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-28|30|251|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-29|30|254|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-30|30|341|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-31|30|348|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-32|30|376|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-33|30|386|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-34|30|417|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-35|30|444|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-36|30|464|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-37|30|469|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-38|30|498|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-39|30|524|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-40|30|529|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-41|30|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-42|30|580|Other deterministic changes|Lower respiratory system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-43|30|588|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-44|30|595|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-45|30|595|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-46|30|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-47|30|605|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-48|30|609|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-49|30|616|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-50|30|621|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-51|30|635|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-52|30|636|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-53|30|656|Other deterministic changes|Lower respiratory system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-54|30|656|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-55|30|657|Other deterministic changes|Lower respiratory system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-56|30|657|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-57|30|658|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-58|30|683|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-59|30|683|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-60|30|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-61|30|695|Other deterministic changes|Lower respiratory system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-62|30|715|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-63|30|724|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-64|30|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-65|30|726|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-66|30|732|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-67|30|733|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-68|30|734|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-69|30|736|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-70|30|740|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-71|30|745|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-72|30|747|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-73|30|749|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-74|30|755|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-75|30|758|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-76|30|759|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-77|30|764|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-78|30|764|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-79|30|774|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-80|30|775|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-81|30|780|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-82|30|780|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-83|30|800|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-84|30|811|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-85|30|812|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-86|30|813|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-87|30|816|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-88|30|832|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-89|30|836|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-90|30|837|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-91|30|844|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-92|30|848|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-93|30|852|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-94|30|868|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-95|30|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-96|30|894|Other deterministic changes|Whole body|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-97|30|906|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-30|XfC-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-30-98|30|983|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-1|31|94|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-2|31|123|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-3|31|127|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-4|31|128|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-5|31|130|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-6|31|131|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-7|31|133|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-8|31|137|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-9|31|140|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-10|31|142|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-11|31|142|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-12|31|146|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-13|31|147|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-14|31|148|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-15|31|148|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-16|31|151|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-17|31|155|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-18|31|158|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-19|31|159|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-20|31|160|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-21|31|160|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-22|31|160|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-23|31|161|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-24|31|165|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-25|31|167|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-26|31|169|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-27|31|171|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-28|31|174|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-29|31|174|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-30|31|176|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-31|31|179|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-32|31|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-33|31|180|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-34|31|180|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-35|31|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-36|31|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-37|31|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-38|31|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-39|31|187|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-40|31|190|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-41|31|190|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-42|31|191|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-43|31|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-44|31|193|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-45|31|193|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-46|31|196|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-47|31|197|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-48|31|198|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-49|31|199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-50|31|199|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-51|31|199|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-52|31|200|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-53|31|204|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-54|31|206|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-55|31|216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-56|31|221|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-57|31|221|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-58|31|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-59|31|227|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-60|31|228|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-61|31|232|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-62|31|233|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-63|31|235|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-64|31|246|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-65|31|246|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-66|31|258|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-67|31|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-68|31|262|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-69|31|268|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-70|31|273|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-71|31|278|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-72|31|279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-73|31|286|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-74|31|303|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-75|31|320|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-76|31|346|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-77|31|346|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-78|31|451|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-79|31|464|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-80|31|468|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-81|31|517|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-82|31|519|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-83|31|531|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-84|31|539|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-85|31|547|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-86|31|549|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-87|31|568|Other deterministic changes|Lower respiratory system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-88|31|585|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-89|31|591|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-90|31|591|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-91|31|623|Other deterministic changes|Lower respiratory system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-92|31|641|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-93|31|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-94|31|651|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-95|31|654|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-96|31|659|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-97|31|664|Other deterministic changes|Lower respiratory system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-98|31|666|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-99|31|685|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-100|31|686|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-101|31|715|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-102|31|720|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-103|31|723|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-104|31|724|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-105|31|734|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-106|31|740|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-107|31|750|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-108|31|761|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-109|31|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-110|31|773|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-111|31|774|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-112|31|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-113|31|782|Other deterministic changes|Lower respiratory system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-114|31|782|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-115|31|785|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-116|31|786|Other deterministic changes|Lower respiratory system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-117|31|791|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-118|31|792|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-119|31|798|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-120|31|798|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-121|31|802|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-122|31|803|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-123|31|805|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-124|31|809|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-125|31|809|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-126|31|812|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-127|31|824|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-128|31|826|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-129|31|831|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-130|31|832|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-131|31|848|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-132|31|848|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-133|31|852|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-134|31|871|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-135|31|873|Other deterministic changes|Lower respiratory system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-136|31|873|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-137|31|884|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-138|31|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-139|31|914|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-140|31|920|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-141|31|922|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-142|31|956|Other deterministic changes|Whole body|n/a|
9-4-31|XfC-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|143 (143 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-31-143|31|965|Other deterministic changes|Whole body|n/a|
9-4-32|XfC-Gy 5,n/a|Sequence:1, Age:28,Type:X-rays whole body,Quantity:500,Unit:roentgens,Application:External exposure, Remarks:whole body 4 fract.1w interval|100 (0 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-1|33|83|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-2|33|84|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-3|33|109|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-4|33|111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-5|33|116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-6|33|118|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-7|33|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-8|33|126|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-9|33|129|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-10|33|130|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-11|33|131|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-12|33|133|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-13|33|133|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-14|33|133|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-15|33|134|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-16|33|134|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-17|33|135|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-18|33|138|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-19|33|138|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-20|33|139|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-21|33|141|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-22|33|144|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-23|33|146|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-24|33|147|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-25|33|147|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-26|33|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-27|33|152|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-28|33|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-29|33|153|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-30|33|153|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-31|33|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-32|33|155|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-33|33|157|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-34|33|160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-35|33|161|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-36|33|162|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-37|33|165|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-38|33|166|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-39|33|168|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-40|33|168|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-41|33|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-42|33|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-43|33|171|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-44|33|172|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-45|33|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-46|33|173|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-47|33|173|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-48|33|178|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-49|33|178|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-50|33|179|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-51|33|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-52|33|181|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-53|33|183|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-54|33|183|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-55|33|184|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-56|33|184|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-57|33|184|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-58|33|185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-59|33|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-60|33|188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-61|33|189|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-62|33|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-63|33|195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-64|33|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-65|33|199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-66|33|199|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-67|33|201|Other deterministic changes|Lower respiratory system|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-68|33|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-69|33|202|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-70|33|204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-71|33|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-72|33|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-73|33|206|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-74|33|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-75|33|209|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-76|33|209|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-77|33|213|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-78|33|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-79|33|215|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-80|33|216|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-81|33|216|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-82|33|217|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-83|33|222|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-84|33|227|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-85|33|229|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-86|33|232|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-87|33|237|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-88|33|244|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-89|33|245|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-90|33|246|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-91|33|262|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-92|33|283|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-93|33|290|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-94|33|404|Other deterministic changes|Lower respiratory system|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-95|33|510|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-96|33|525|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-97|33|553|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-98|33|683|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-99|33|703|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-100|33|715|Other deterministic changes|Whole body|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-101|33|784|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-33|XfC-Gy 7,n/a|1| 28|X-rays whole body|700|roentgens|External exposure| whole body 4 fract.1w interval|102 (102 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|48 for pathol.|9-4-33-102|33|795|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-1|34|32|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-2|34|33|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-3|34|35|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-4|34|36|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-5|34|42|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-6|34|49|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-7|34|115|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-8|34|115|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-9|34|126|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-10|34|131|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-11|34|137|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-12|34|139|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-13|34|140|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-14|34|145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-15|34|147|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-16|34|148|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-17|34|148|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-18|34|149|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-19|34|152|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-20|34|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-21|34|153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-22|34|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-23|34|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-24|34|154|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-25|34|155|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-26|34|158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-27|34|159|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-28|34|160|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-29|34|162|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-30|34|163|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-31|34|168|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-32|34|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-33|34|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-34|34|171|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-35|34|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-36|34|175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-37|34|176|Other deterministic changes|Lower respiratory system|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-38|34|176|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-39|34|177|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-40|34|178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-41|34|179|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-42|34|181|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-43|34|181|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-44|34|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-45|34|182|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-46|34|184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-47|34|184|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-48|34|188|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-49|34|188|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-50|34|189|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-51|34|190|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-52|34|193|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-53|34|200|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-54|34|203|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-55|34|204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-56|34|205|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-57|34|207|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-58|34|208|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-59|34|208|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-60|34|212|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-61|34|214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-62|34|214|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-63|34|217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-64|34|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-65|34|220|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-66|34|221|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-67|34|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-68|34|226|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-69|34|227|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-70|34|232|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-71|34|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-72|34|239|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-73|34|240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-74|34|241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-75|34|241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-76|34|241|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-77|34|242|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-78|34|244|Other deterministic changes|Lower respiratory system|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-79|34|244|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-80|34|244|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-81|34|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-82|34|249|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-83|34|249|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-84|34|253|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-85|34|255|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-86|34|255|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-87|34|256|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-88|34|256|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-89|34|256|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-90|34|259|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-91|34|265|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-92|34|269|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-93|34|271|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-94|34|296|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-95|34|308|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-96|34|325|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-97|34|340|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-98|34|355|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-99|34|492|Other deterministic changes|Whole body|n/a|
9-4-34|XfC-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|100 (100 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|40 for pathol.|9-4-34-100|34|530|Other deterministic changes|Whole body|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-1|35|31|Other deterministic changes|Whole body|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-2|35|32|Other deterministic changes|Whole body|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-3|35|33|Other deterministic changes|Whole body|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-4|35|36|Other deterministic changes|Whole body|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-5|35|37|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-6|35|50|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-35|XfC-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|7 (7 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|3 for pathol.|9-4-35-7|35|187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-1|36|56|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-2|36|119|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-3|36|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-4|36|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-5|36|186|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-6|36|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-7|36|251|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-8|36|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-9|36|297|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-10|36|322|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-11|36|352|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-12|36|449|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-13|36|466|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-14|36|514|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-15|36|521|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-16|36|525|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-17|36|546|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-18|36|557|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-19|36|586|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-20|36|589|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-21|36|592|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-22|36|594|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-23|36|598|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-24|36|598|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-25|36|600|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-26|36|601|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-27|36|607|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-28|36|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-29|36|615|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-30|36|628|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-31|36|631|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-32|36|645|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-33|36|653|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-34|36|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-35|36|661|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-36|36|661|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-37|36|662|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-38|36|662|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-39|36|663|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-40|36|669|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-41|36|672|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-42|36|672|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-43|36|677|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-44|36|680|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-45|36|683|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-46|36|684|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-47|36|691|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-48|36|698|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-49|36|710|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-50|36|711|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-51|36|713|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-52|36|716|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-53|36|727|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-54|36|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-55|36|747|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-56|36|750|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-57|36|752|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-58|36|757|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-59|36|759|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-60|36|764|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-61|36|765|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-62|36|769|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-63|36|769|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-64|36|771|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-65|36|778|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-66|36|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-67|36|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-68|36|789|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-69|36|789|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-70|36|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-71|36|793|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-72|36|794|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-73|36|795|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-74|36|796|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-75|36|798|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-76|36|798|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-77|36|798|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-78|36|799|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-79|36|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-80|36|806|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-81|36|808|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-82|36|808|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-83|36|810|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-84|36|813|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-85|36|816|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-86|36|825|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-87|36|829|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-88|36|830|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-89|36|832|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-90|36|833|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-91|36|833|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-92|36|835|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-93|36|836|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-94|36|836|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-95|36|838|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-96|36|840|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-97|36|862|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-98|36|865|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-99|36|874|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-100|36|885|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-101|36|901|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-102|36|908|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-103|36|919|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-104|36|922|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-105|36|949|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|1| 28|X-rays whole body|200|roentgens|External exposure| whole body 4 fract.1w interval|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-106|36|950|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-1|36|56|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-2|36|119|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-3|36|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-4|36|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-5|36|186|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-6|36|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-7|36|251|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-8|36|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-9|36|297|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-10|36|322|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-11|36|352|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-12|36|449|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-13|36|466|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-14|36|514|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-15|36|521|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-16|36|525|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-17|36|546|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-18|36|557|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-19|36|586|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-20|36|589|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-21|36|592|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-22|36|594|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-23|36|598|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-24|36|598|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-25|36|600|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-26|36|601|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-27|36|607|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-28|36|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-29|36|615|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-30|36|628|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-31|36|631|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-32|36|645|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-33|36|653|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-34|36|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-35|36|661|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-36|36|661|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-37|36|662|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-38|36|662|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-39|36|663|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-40|36|669|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-41|36|672|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-42|36|672|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-43|36|677|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-44|36|680|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-45|36|683|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-46|36|684|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-47|36|691|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-48|36|698|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-49|36|710|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-50|36|711|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-51|36|713|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-52|36|716|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-53|36|727|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-54|36|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-55|36|747|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-56|36|750|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-57|36|752|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-58|36|757|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-59|36|759|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-60|36|764|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-61|36|765|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-62|36|769|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-63|36|769|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-64|36|771|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-65|36|778|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-66|36|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-67|36|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-68|36|789|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-69|36|789|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-70|36|791|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-71|36|793|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-72|36|794|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-73|36|795|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-74|36|796|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-75|36|798|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-76|36|798|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-77|36|798|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-78|36|799|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-79|36|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-80|36|806|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-81|36|808|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-82|36|808|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-83|36|810|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-84|36|813|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-85|36|816|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-86|36|825|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-87|36|829|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-88|36|830|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-89|36|832|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-90|36|833|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-91|36|833|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-92|36|835|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-93|36|836|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-94|36|836|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-95|36|838|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-96|36|840|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-97|36|862|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-98|36|865|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-99|36|874|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-100|36|885|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-101|36|901|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-102|36|908|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-103|36|919|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-104|36|922|Other deterministic changes|Whole body|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-105|36|949|Other deterministic changes|Lower respiratory system|n/a|
9-4-36|XfCM-Gy 2,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|106 (106 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|42 for pathol.|9-4-36-106|36|950|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-1|37|73|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-2|37|150|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-3|37|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-4|37|159|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-5|37|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-6|37|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-7|37|186|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-8|37|197|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-9|37|207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-10|37|222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-11|37|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-12|37|226|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-13|37|236|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-14|37|238|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-15|37|284|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-16|37|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-17|37|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-18|37|426|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-19|37|431|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-20|37|489|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-21|37|522|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-22|37|528|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-23|37|530|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-24|37|551|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-25|37|555|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-26|37|572|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-27|37|575|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-28|37|587|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-29|37|608|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-30|37|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-31|37|621|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-32|37|623|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-33|37|629|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-34|37|634|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-35|37|636|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-36|37|639|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-37|37|642|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-38|37|643|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-39|37|650|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-40|37|651|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-41|37|655|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-42|37|659|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-43|37|659|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-44|37|659|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-45|37|676|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-46|37|692|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-47|37|695|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-48|37|695|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-49|37|697|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-50|37|697|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-51|37|699|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-52|37|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-53|37|707|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-54|37|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-55|37|708|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-56|37|720|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-57|37|723|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-58|37|727|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-59|37|729|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-60|37|733|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-61|37|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-62|37|737|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-63|37|747|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-64|37|747|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-65|37|748|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-66|37|754|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-67|37|762|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-68|37|768|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-69|37|769|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-70|37|770|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-71|37|771|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-72|37|773|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-73|37|780|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-74|37|784|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-75|37|784|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-76|37|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-77|37|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-78|37|787|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-79|37|788|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-80|37|789|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-81|37|789|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-82|37|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-83|37|794|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-84|37|802|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-85|37|803|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-86|37|809|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-87|37|809|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-88|37|811|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-89|37|811|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-90|37|827|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-91|37|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-92|37|832|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-93|37|832|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-94|37|834|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-95|37|837|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-96|37|843|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-97|37|844|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-98|37|848|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-99|37|863|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-100|37|865|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-101|37|873|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-102|37|874|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-103|37|900|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-104|37|905|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-105|37|905|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-106|37|929|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-107|37|984|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|1| 28|X-rays whole body|300|roentgens|External exposure| whole body 4 fract.1w interval|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-108|37|998|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-1|37|73|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-2|37|150|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-3|37|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-4|37|159|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-5|37|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-6|37|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-7|37|186|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-8|37|197|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-9|37|207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-10|37|222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-11|37|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-12|37|226|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-13|37|236|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-14|37|238|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-15|37|284|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-16|37|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-17|37|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-18|37|426|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-19|37|431|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-20|37|489|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-21|37|522|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-22|37|528|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-23|37|530|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-24|37|551|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-25|37|555|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-26|37|572|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-27|37|575|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-28|37|587|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-29|37|608|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-30|37|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-31|37|621|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-32|37|623|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-33|37|629|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-34|37|634|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-35|37|636|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-36|37|639|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-37|37|642|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-38|37|643|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-39|37|650|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-40|37|651|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-41|37|655|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-42|37|659|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-43|37|659|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-44|37|659|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-45|37|676|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-46|37|692|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-47|37|695|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-48|37|695|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-49|37|697|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-50|37|697|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-51|37|699|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-52|37|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-53|37|707|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-54|37|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-55|37|708|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-56|37|720|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-57|37|723|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-58|37|727|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-59|37|729|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-60|37|733|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-61|37|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-62|37|737|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-63|37|747|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-64|37|747|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-65|37|748|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-66|37|754|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-67|37|762|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-68|37|768|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-69|37|769|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-70|37|770|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-71|37|771|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-72|37|773|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-73|37|780|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-74|37|784|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-75|37|784|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-76|37|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-77|37|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-78|37|787|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-79|37|788|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-80|37|789|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-81|37|789|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-82|37|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-83|37|794|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-84|37|802|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-85|37|803|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-86|37|809|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-87|37|809|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-88|37|811|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-89|37|811|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-90|37|827|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-91|37|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-92|37|832|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-93|37|832|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-94|37|834|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-95|37|837|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-96|37|843|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-97|37|844|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-98|37|848|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-99|37|863|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-100|37|865|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-101|37|873|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-102|37|874|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-103|37|900|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-104|37|905|Other deterministic changes|Lower respiratory system|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-105|37|905|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-106|37|929|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-107|37|984|Other deterministic changes|Whole body|n/a|
9-4-37|XfCM-Gy 3,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|108 (108 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|47 for pathol.|9-4-37-108|37|998|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-1|38|48|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-2|38|110|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-3|38|152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-4|38|158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-5|38|163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-6|38|172|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-7|38|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-8|38|174|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-9|38|180|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-10|38|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-11|38|186|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-12|38|214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-13|38|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-14|38|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-15|38|242|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-16|38|245|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-17|38|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-18|38|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-19|38|360|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-20|38|404|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-21|38|470|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-22|38|503|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-23|38|509|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-24|38|516|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-25|38|527|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-26|38|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-27|38|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-28|38|533|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-29|38|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-30|38|543|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-31|38|576|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-32|38|593|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-33|38|598|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-34|38|613|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-35|38|628|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-36|38|629|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-37|38|629|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-38|38|631|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-39|38|641|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-40|38|645|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-41|38|655|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-42|38|658|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-43|38|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-44|38|684|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-45|38|686|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-46|38|697|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-47|38|697|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-48|38|716|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-49|38|717|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-50|38|718|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-51|38|719|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-52|38|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-53|38|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-54|38|757|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-55|38|760|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-56|38|761|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-57|38|763|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-58|38|764|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-59|38|767|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-60|38|769|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-61|38|771|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-62|38|772|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-63|38|775|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-64|38|775|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-65|38|775|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-66|38|786|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-67|38|788|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-68|38|802|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-69|38|803|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-70|38|810|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-71|38|813|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-72|38|822|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-73|38|822|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-74|38|822|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-75|38|827|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-76|38|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-77|38|830|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-78|38|832|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-79|38|832|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-80|38|833|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-81|38|834|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-82|38|844|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-83|38|844|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-84|38|845|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-85|38|848|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-86|38|850|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-87|38|850|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-88|38|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-89|38|863|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-90|38|869|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-91|38|871|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-92|38|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-93|38|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-94|38|927|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-95|38|928|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-96|38|939|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|1| 28|X-rays whole body|400|roentgens|External exposure| whole body 4 fract.1w interval|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-97|38|948|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-1|38|48|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-2|38|110|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-3|38|152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-4|38|158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-5|38|163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-6|38|172|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-7|38|173|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-8|38|174|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-9|38|180|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-10|38|182|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-11|38|186|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-12|38|214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-13|38|223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-14|38|235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-15|38|242|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-16|38|245|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-17|38|267|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-18|38|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-19|38|360|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-20|38|404|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-21|38|470|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-22|38|503|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-23|38|509|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-24|38|516|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-25|38|527|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-26|38|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-27|38|532|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-28|38|533|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-29|38|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-30|38|543|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-31|38|576|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-32|38|593|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-33|38|598|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-34|38|613|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-35|38|628|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-36|38|629|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-37|38|629|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-38|38|631|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-39|38|641|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-40|38|645|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-41|38|655|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-42|38|658|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-43|38|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-44|38|684|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-45|38|686|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-46|38|697|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-47|38|697|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-48|38|716|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-49|38|717|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-50|38|718|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-51|38|719|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-52|38|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-53|38|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-54|38|757|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-55|38|760|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-56|38|761|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-57|38|763|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-58|38|764|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-59|38|767|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-60|38|769|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-61|38|771|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-62|38|772|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-63|38|775|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-64|38|775|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-65|38|775|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-66|38|786|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-67|38|788|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-68|38|802|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-69|38|803|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-70|38|810|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-71|38|813|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-72|38|822|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-73|38|822|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-74|38|822|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-75|38|827|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-76|38|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-77|38|830|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-78|38|832|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-79|38|832|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-80|38|833|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-81|38|834|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-82|38|844|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-83|38|844|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-84|38|845|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-85|38|848|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-86|38|850|Other deterministic changes|Lower respiratory system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-87|38|850|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-88|38|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-89|38|863|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-90|38|869|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-91|38|871|Other deterministic changes|Whole body|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-92|38|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-93|38|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-94|38|927|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-95|38|928|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-96|38|939|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-38|XfCA-Gy 4,n/a|2| 84|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|97 (97 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|45 for pathol.|9-4-38-97|38|948|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-1|39|86|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-2|39|125|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-3|39|129|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-4|39|137|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-5|39|139|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-6|39|149|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-7|39|152|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-8|39|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-9|39|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-10|39|165|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-11|39|167|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-12|39|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-13|39|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-14|39|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-15|39|176|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-16|39|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-17|39|185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-18|39|195|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-19|39|199|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-20|39|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-21|39|212|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-22|39|216|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-23|39|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-24|39|239|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-25|39|241|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-26|39|260|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-27|39|261|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-28|39|275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-29|39|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-30|39|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-31|39|330|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-32|39|353|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-33|39|392|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-34|39|433|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-35|39|433|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-36|39|523|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-37|39|555|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-38|39|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-39|39|599|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-40|39|600|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-41|39|605|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-42|39|609|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-43|39|616|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-44|39|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-45|39|623|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-46|39|629|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-47|39|635|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-48|39|636|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-49|39|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-50|39|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-51|39|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-52|39|648|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-53|39|651|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-54|39|653|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-55|39|678|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-56|39|679|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-57|39|687|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-58|39|688|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-59|39|693|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-60|39|695|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-61|39|697|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-62|39|697|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-63|39|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-64|39|722|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-65|39|727|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-66|39|730|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-67|39|734|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-68|39|734|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-69|39|738|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-70|39|739|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-71|39|751|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-72|39|755|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-73|39|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-74|39|763|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-75|39|770|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-76|39|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-77|39|787|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-78|39|792|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-79|39|796|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-80|39|798|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-81|39|800|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-82|39|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-83|39|806|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-84|39|810|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-85|39|820|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-86|39|825|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-87|39|827|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-88|39|830|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-89|39|836|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-90|39|837|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-91|39|837|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-92|39|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-93|39|844|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-94|39|844|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-95|39|846|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-96|39|862|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-97|39|888|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|1| 28|X-rays whole body|500|roentgens|External exposure| whole body 4 fract.1w interval|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-98|39|937|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-1|39|86|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-2|39|125|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-3|39|129|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-4|39|137|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-5|39|139|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-6|39|149|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-7|39|152|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-8|39|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-9|39|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-10|39|165|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-11|39|167|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-12|39|170|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-13|39|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-14|39|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-15|39|176|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-16|39|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-17|39|185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-18|39|195|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-19|39|199|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-20|39|211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-21|39|212|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-22|39|216|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-23|39|231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-24|39|239|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-25|39|241|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-26|39|260|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-27|39|261|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-28|39|275|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-29|39|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-30|39|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-31|39|330|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-32|39|353|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-33|39|392|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-34|39|433|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-35|39|433|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-36|39|523|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-37|39|555|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-38|39|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-39|39|599|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-40|39|600|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-41|39|605|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-42|39|609|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-43|39|616|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-44|39|621|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-45|39|623|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-46|39|629|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-47|39|635|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-48|39|636|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-49|39|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-50|39|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-51|39|642|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-52|39|648|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-53|39|651|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-54|39|653|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-55|39|678|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-56|39|679|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-57|39|687|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-58|39|688|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-59|39|693|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-60|39|695|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-61|39|697|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-62|39|697|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-63|39|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-64|39|722|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-65|39|727|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-66|39|730|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-67|39|734|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-68|39|734|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-69|39|738|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-70|39|739|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-71|39|751|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-72|39|755|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-73|39|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-74|39|763|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-75|39|770|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-76|39|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-77|39|787|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-78|39|792|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-79|39|796|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-80|39|798|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-81|39|800|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-82|39|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-83|39|806|Other deterministic changes|Whole body|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-84|39|810|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-85|39|820|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-86|39|825|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-87|39|827|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-88|39|830|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-89|39|836|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-90|39|837|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-91|39|837|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-92|39|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-93|39|844|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-94|39|844|Other deterministic changes|Lower respiratory system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-95|39|846|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-96|39|862|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-97|39|888|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-39|XfCM-Gy 5,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|98 (98 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|55 for pathol.|9-4-39-98|39|937|Other deterministic changes|Whole body|n/a|
9-4-40|XfCM-Gy 7,n/a|Sequence:1, Age:28,Type:X-rays whole body,Quantity:700,Unit:roentgens,Application:External exposure, Remarks:whole body single|104 (0 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-40|XfCM-Gy 7,n/a|Sequence:2, Age:28,Type:Mix AET, 5HT, MEA, glutathion,Quantity:,Unit:milligrams per animal,Application:Injection, intraperitoneal, Remarks:8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|104 (0 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|Lifespan study macro/microscopic pathology|No information on individuals available for this study
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-1|41|35|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-2|41|54|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-3|41|62|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-4|41|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-5|41|154|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-6|41|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-7|41|161|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-8|41|161|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-9|41|166|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-10|41|170|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-11|41|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-12|41|171|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-13|41|172|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-14|41|178|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-15|41|179|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-16|41|179|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-17|41|181|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-18|41|182|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-19|41|190|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-20|41|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-21|41|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-22|41|198|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-23|41|202|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-24|41|203|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-25|41|209|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-26|41|209|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-27|41|212|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-28|41|219|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-29|41|224|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-30|41|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-31|41|228|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-32|41|229|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-33|41|230|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-34|41|232|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-35|41|232|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-36|41|235|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-37|41|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-38|41|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-39|41|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-40|41|250|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-41|41|254|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-42|41|258|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-43|41|259|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-44|41|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-45|41|265|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-46|41|266|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-47|41|266|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-48|41|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-49|41|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-50|41|275|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-51|41|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-52|41|284|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-53|41|285|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-54|41|294|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-55|41|299|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-56|41|303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-57|41|329|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-58|41|332|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-59|41|345|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-60|41|348|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-61|41|355|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-62|41|366|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-63|41|381|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-64|41|403|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-65|41|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-66|41|412|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-67|41|412|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-68|41|413|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-69|41|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-70|41|448|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-71|41|462|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-72|41|468|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-73|41|486|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-74|41|492|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-75|41|500|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-76|41|508|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-77|41|515|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-78|41|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-79|41|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-80|41|536|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-81|41|537|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-82|41|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-83|41|607|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-84|41|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-85|41|618|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-86|41|651|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-87|41|688|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-88|41|695|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-89|41|704|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-90|41|709|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-91|41|714|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-92|41|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-93|41|748|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-94|41|749|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-95|41|760|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-96|41|760|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-97|41|768|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-98|41|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-99|41|784|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-100|41|785|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-101|41|803|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-102|41|831|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-41|XfCM-Gy 10,n/a|1| 28|X-rays whole body|1000|roentgens|External exposure| whole body 4 fract.1w interval|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-103|41|886|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-1|41|35|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-2|41|54|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-3|41|62|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-4|41|125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-5|41|154|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-6|41|159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-7|41|161|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-8|41|161|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-9|41|166|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-10|41|170|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-11|41|171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-12|41|171|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-13|41|172|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-14|41|178|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-15|41|179|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-16|41|179|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-17|41|181|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-18|41|182|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-19|41|190|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-20|41|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-21|41|197|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-22|41|198|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-23|41|202|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-24|41|203|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-25|41|209|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-26|41|209|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-27|41|212|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-28|41|219|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-29|41|224|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-30|41|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-31|41|228|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-32|41|229|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-33|41|230|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-34|41|232|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-35|41|232|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-36|41|235|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-37|41|238|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-38|41|244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-39|41|247|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-40|41|250|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-41|41|254|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-42|41|258|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-43|41|259|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-44|41|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-45|41|265|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-46|41|266|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-47|41|266|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-48|41|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-49|41|270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-50|41|275|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-51|41|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-52|41|284|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-53|41|285|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-54|41|294|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-55|41|299|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-56|41|303|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-57|41|329|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-58|41|332|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-59|41|345|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-60|41|348|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-61|41|355|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-62|41|366|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-63|41|381|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-64|41|403|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-65|41|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-66|41|412|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-67|41|412|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-68|41|413|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-69|41|437|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-70|41|448|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-71|41|462|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-72|41|468|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-73|41|486|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-74|41|492|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-75|41|500|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-76|41|508|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-77|41|515|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-78|41|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-79|41|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-80|41|536|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-81|41|537|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-82|41|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-83|41|607|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-84|41|614|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-85|41|618|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-86|41|651|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-87|41|688|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-88|41|695|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-89|41|704|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-90|41|709|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-91|41|714|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-92|41|723|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-93|41|748|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-94|41|749|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-95|41|760|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-96|41|760|Other deterministic changes|Lower respiratory system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-97|41|768|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-98|41|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-99|41|784|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-100|41|785|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-101|41|803|Other deterministic changes|Whole body|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-102|41|831|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-41|XfCM-Gy 10,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|103 (103 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|37 for pathol.|9-4-41-103|41|886|Other deterministic changes|Whole body|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-1|42|32|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-2|42|139|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-3|42|160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-4|42|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-5|42|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-6|42|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-7|42|188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-8|42|189|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-9|42|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-10|42|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-11|42|196|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-12|42|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-13|42|205|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-14|42|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-15|42|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-16|42|234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-17|42|245|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-18|42|252|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-19|42|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-20|42|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-21|42|277|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-22|42|279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-23|42|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-24|42|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-25|42|312|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-26|42|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-27|42|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-28|42|362|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-29|42|367|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-30|42|405|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-31|42|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-32|42|488|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-33|42|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-34|42|553|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-35|42|556|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-36|42|563|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-37|42|569|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-38|42|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-39|42|620|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-40|42|641|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-41|42|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-42|42|703|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-43|42|720|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|1| 28|X-rays whole body|1500|roentgens|External exposure| whole body 4 fract.1w interval|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-44|42|750|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-1|42|32|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-2|42|139|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-3|42|160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-4|42|172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-5|42|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-6|42|186|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-7|42|188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-8|42|189|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-9|42|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-10|42|191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-11|42|196|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-12|42|201|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-13|42|205|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-14|42|220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-15|42|226|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-16|42|234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-17|42|245|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-18|42|252|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-19|42|260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-20|42|268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-21|42|277|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-22|42|279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-23|42|284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-24|42|310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-25|42|312|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-26|42|327|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-27|42|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-28|42|362|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-29|42|367|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-30|42|405|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-31|42|447|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-32|42|488|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-33|42|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-34|42|553|Other deterministic changes|Lower respiratory system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-35|42|556|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-36|42|563|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-37|42|569|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-38|42|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-39|42|620|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-40|42|641|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-41|42|654|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-42|42|703|Neoplasia systemic|Haematolymphatic system|n/a|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-43|42|720|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
9-4-42|XfCM-Gy 15,n/a|2| 28|Mix AET, 5HT, MEA, glutathion||milligrams per animal|Injection, intraperitoneal| 8mg AET 1mg 5-HT 5mg MEA 15mg cysteine ip, 16mg glutathion  oral|44 (44 in ERA)|Mouse|Mouse, C57BL/Cnb|Male|Juvenile|44 for pathol.|9-4-42-44|42|750|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 1 - cell and tissue damage|
		
